| 1 |
A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease. N Engl J Med. 2009 Nov 19;361(21):2019-32.
|
| 2 |
URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2790).
|
| 3 |
ClinicalTrials.gov (NCT02268994) KRX-0502 (Ferric Citrate) for the Treatment of IDA in Adult Subjects With NDD-CKD. U.S. National Institutes of Health.
|
| 4 |
ClinicalTrials.gov (NCT01942460) Ferumoxytol for Iron-Deficiency Anemia in Chronic Kidney Disease and Peritoneal Dialysis Patients. U.S. National Institutes of Health.
|
| 5 |
FDA Approved Drug Products from FDA Official Website. 2022. Application Number: 215341.
|
| 6 |
Flucloxacillin and paracetamol induced pyroglutamic acidosis. BMJ Case Rep. 2021 Jan 8;14(1):e237536.
|
| 7 |
ClinicalTrials.gov (NCT05099770) A Phase 3 Randomized Controlled Study of Renal Autologous Cell Therapy (REACT) in Subjects With Type 2 Diabetes and Chronic Kidney Disease (REGEN-006). U.S.National Institutes of Health.
|
| 8 |
ClinicalTrials.gov (NCT05407389) An Open-Label Rollover Extension Phase 2 Clinical Trial To Evaluate The Long-Term Safety And Efficacy Of KT-301 (Formerly US-APR2020) In Subjects With CKD IV Completing The US-APR2020-01 Study. U.S.National Institutes of Health.
|
| 9 |
ClinicalTrials.gov (NCT04987294) A Randomized, Double-Blind, Placebo-Controlled Study of ALLN-346 (Engineered Urate Oxidase) in Hyperuricemic Subjects With Gout and Mild to Moderate Chronic Kidney Disease. U.S.National Institutes of Health.
|
| 10 |
Clinical pipeline report, company report or official report of Ardelyx.
|
| 11 |
ClinicalTrials.gov (NCT01843790) A Phase 2a Study of Weekly Doses of GCS-100 in Patients With Chronic Kidney Disease. U.S. National Institutes of Health.
|
| 12 |
ClinicalTrials.gov (NCT02194465) A Study of LY2623091 in Participants With High Blood Pressure. U.S. National Institutes of Health.
|
| 13 |
ClinicalTrials.gov (NCT02525263) Autologous Neo-Kidney Augment (NKA) in Patients With Type 2 Diabetes and Chronic Kidney Disease (CKD) (RMCL-CL001). U.S. National Institutes of Health.
|
| 14 |
ClinicalTrials.gov (NCT04507061) A Randomized, Double-blind, Placebo-controlled, Multi-center Study to Assess the Safety and Efficacy of Individually Titrated Oral Doses of Runcaciguat in Subjects With Clinical Diagnosis of Chronic Kidney Disease With Diabetes and/or Hypertension and at Least One Cardiovascular Comorbidity. U.S.National Institutes of Health.
|
| 15 |
ClinicalTrials.gov (NCT01774981) Study of LY3016859 in Participants With Diabetic Nephropathy. U.S. National Institutes of Health.
|
| 16 |
ClinicalTrials.gov (NCT05351047) A Phase I, Randomized, Single-blind, Placebo-controlled Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD2373 Following Multiple Ascending Dose Administration to Healthy Male Participants of Sub-Saharan West African Ancestry. U.S.National Institutes of Health.
|
| 17 |
ClinicalTrials.gov (NCT04365218) A Phase I Randomized, Blinded, Placebo-controlled Study to Evaluate the Safety and Pharmacokinetics of MEDI8367 Administered as Single Ascending Doses in Healthy Subjects, and as a Single Dose in Healthy Subjects of Japanese-descent and in Subjects With Chronic Kidney Disease. U.S.National Institutes of Health.
|
| 18 |
The activin receptor is stimulated in the skeleton, vasculature, heart, and kidney during chronic kidney disease.Kidney Int. 2018 Jan;93(1):147-158. doi: 10.1016/j.kint.2017.06.016. Epub 2017 Aug 23.
|
| 19 |
Direct-acting Antivirals for HIV/HCV Co-infected Individuals: As Good as it Gets?.Curr HIV Res. 2017;15(6):422-433. doi: 10.2174/1570162X15666171108125255.
|
| 20 |
Practical Considerations for APOL1 Genotyping in the Living Kidney Donor Evaluation.Transplantation. 2020 Jan;104(1):27-32. doi: 10.1097/TP.0000000000002933.
|
| 21 |
Re-admissions treble the risk of late mortality after primary total hiparthroplasty.Int Orthop. 2018 Sep;42(9):2015-2023. doi: 10.1007/s00264-018-3876-0. Epub 2018 Mar 10.
|
| 22 |
Erythropoietin attenuates vascular calcification by inhibiting endoplasmic reticulum stress in rats with chronic kidney disease.Peptides. 2020 Jan;123:170181. doi: 10.1016/j.peptides.2019.170181. Epub 2019 Nov 2.
|
| 23 |
Plasma copeptin as a predictor of kidney disease.Nephrol Dial Transplant. 2019 Jan 1;34(1):74-82. doi: 10.1093/ndt/gfy017.
|
| 24 |
Effect of cardiac resynchronization therapy on the risk of ventricular tachyarrhythmias in patients with chronic kidney disease.Ann Noninvasive Electrocardiol. 2017 May;22(3):e12404. doi: 10.1111/anec.12404. Epub 2016 Sep 15.
|
| 25 |
A randomized trial of serological and cellular responses to hepatitis B vaccination in chronic kidney disease.PLoS One. 2018 Oct 10;13(10):e0204477. doi: 10.1371/journal.pone.0204477. eCollection 2018.
|
| 26 |
CD36 in chronic kidney disease: novel insights and therapeutic opportunities.Nat Rev Nephrol. 2017 Dec;13(12):769-781. doi: 10.1038/nrneph.2017.126. Epub 2017 Sep 18.
|
| 27 |
Genome-wide association and functional follow-up reveals new loci for kidney function.PLoS Genet. 2012;8(3):e1002584. doi: 10.1371/journal.pgen.1002584. Epub 2012 Mar 29.
|
| 28 |
Accumulation of uraemic toxins is reflected only partially by estimated GFR in paediatric patients with chronic kidney disease.Pediatr Nephrol. 2018 Feb;33(2):315-323. doi: 10.1007/s00467-017-3802-5. Epub 2017 Sep 22.
|
| 29 |
The G-protein coupled receptor ChemR23 determines smooth muscle cell phenotypic switching to enhance high phosphate-induced vascular calcification.Cardiovasc Res. 2019 Aug 1;115(10):1557-1566. doi: 10.1093/cvr/cvy316.
|
| 30 |
Circulating cathepsin-S levels correlate with GFR decline and sTNFR1 and sTNFR2 levels in mice and humans.Sci Rep. 2017 Feb 27;7:43538. doi: 10.1038/srep43538.
|
| 31 |
CUBN as a novel locus for end-stage renal disease: insights from renal transplantation.PLoS One. 2012;7(5):e36512. doi: 10.1371/journal.pone.0036512. Epub 2012 May 4.
|
| 32 |
Modulation of aldosterone levels by aldosterone synthase promoter polymorphism and association with eGFR decline in patients with chronic kidney disease.Discov Med. 2018 Dec;26(145):251-260.
|
| 33 |
Effect of Chronic Kidney Disease on Nonrenal Elimination Pathways: A Systematic Assessment of CYP1A2, CYP2C8, CYP2C9, CYP2C19, and OATP.Clin Pharmacol Ther. 2018 May;103(5):854-867. doi: 10.1002/cpt.807. Epub 2017 Oct 9.
|
| 34 |
Outcomes for Inappropriate Renal Dose Adjustment of Dipeptidyl Peptidase-4 Inhibitors in Patients With Type 2 Diabetes Mellitus: Population-Based Study.Mayo Clin Proc. 2020 Jan;95(1):101-112. doi: 10.1016/j.mayocp.2019.06.010. Epub 2019 Dec 4.
|
| 35 |
Mechanism of Glucagon-Like Peptide 1 Improvements in Type 2 Diabetes Mellitus and Obesity.Curr Obes Rep. 2019 Sep;8(3):284-291. doi: 10.1007/s13679-019-00350-4.
|
| 36 |
FGFR4 does not contribute to progression of chronic kidney disease.Sci Rep. 2019 Oct 1;9(1):14023. doi: 10.1038/s41598-019-50669-0.
|
| 37 |
SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by the EURECA-m and the DIABESITY working groups of the ERA-EDTA.Nephrol Dial Transplant. 2019 Feb 1;34(2):208-230. doi: 10.1093/ndt/gfy407.
|
| 38 |
Effect of Hepatic Organic Anion-Transporting Polypeptide 1B Inhibition and Chronic Kidney Disease on the Pharmacokinetics of a Liver-Targeted Glucokinase Activator: A Model-Based Evaluation.Clin Pharmacol Ther. 2019 Oct;106(4):792-802. doi: 10.1002/cpt.1419. Epub 2019 Apr 8.
|
| 39 |
A review of renal GH/IGF1 family gene expression in chronic kidney diseases.Growth Horm IGF Res. 2019 Oct-Dec;48-49:1-4. doi: 10.1016/j.ghir.2019.07.001. Epub 2019 Jul 16.
|
| 40 |
Identification of a novel loss-of-function mutation of the GLA gene in a Chinese Han family with Fabry disease.BMC Med Genet. 2018 Dec 27;19(1):219. doi: 10.1186/s12881-018-0734-2.
|
| 41 |
EGFR drives the progression of AKI to CKD through HIPK2 overexpression.Theranostics. 2019 Apr 13;9(9):2712-2726. doi: 10.7150/thno.31424. eCollection 2019.
|
| 42 |
The association of HLA-G polymorphisms and the synergistic effect of sMICA and sHLA-G with chronic kidney disease and allograft acceptance.PLoS One. 2019 Feb 22;14(2):e0212750. doi: 10.1371/journal.pone.0212750. eCollection 2019.
|
| 43 |
Fu Brick Tea Alleviates Chronic Kidney Disease of Rats with High Fat Diet Consumption through Attenuating Insulin Resistance in Skeletal Muscle.J Agric Food Chem. 2019 Mar 13;67(10):2839-2847. doi: 10.1021/acs.jafc.8b06927. Epub 2019 Mar 4.
|
| 44 |
Utility of Cardiac Biomarkers in the Setting of Kidney Disease.Nephron. 2019;141(4):227-235. doi: 10.1159/000495946. Epub 2019 Feb 6.
|
| 45 |
Association of lipoprotein(a) and coronary artery disease in 1003 patients with stage 3-5 chronic kidney disease undergoing coronary angiography.Coron Artery Dis. 2019 Mar;30(2):137-142. doi: 10.1097/MCA.0000000000000692.
|
| 46 |
Identification of serum metabolites associating with chronic kidney disease progression and anti-fibrotic effect of 5-methoxytryptophan.Nat Commun. 2019 Apr 1;10(1):1476. doi: 10.1038/s41467-019-09329-0.
|
| 47 |
The interplay between microbiota-dependent metabolite trimethylamine N-oxide, Transforming growth factor /SMAD signaling and inflammasome activation in chronic kidney disease patients: A new mechanistic perspective.J Cell Biochem. 2019 Sep;120(9):14476-14485. doi: 10.1002/jcb.28707. Epub 2019 Apr 19.
|
| 48 |
Relation of multi-marker panel to incident chronic kidney disease and rapid kidney function decline in African Americans: the Jackson Heart Study.BMC Nephrol. 2018 Sep 20;19(1):239. doi: 10.1186/s12882-018-1026-y.
|
| 49 |
Urinary Amino-Terminal Pro-C-Type Natriuretic Peptide: A Novel Marker of Chronic Kidney Disease in Diabetes.Clin Chem. 2019 Oct;65(10):1248-1257. doi: 10.1373/clinchem.2019.306910. Epub 2019 Aug 20.
|
| 50 |
Mineralocorticoid Receptor Antagonists and Renal Outcomes in Heart Failure Patients with and without Chronic Kidney Disease.Cardiorenal Med. 2020;10(1):32-41. doi: 10.1159/000503223. Epub 2019 Oct 30.
|
| 51 |
The brown fat-secreted adipokine neuregulin 4 is decreased in human and murine chronic kidney disease.Eur J Endocrinol. 2019 Aug;181(2):151-159. doi: 10.1530/EJE-19-0017.
|
| 52 |
Adaptor protein is a new therapeutic target in chronic kidney disease.Kidney Int. 2017 Dec;92(6):1312-1314. doi: 10.1016/j.kint.2017.06.012.
|
| 53 |
Cinacalcet attenuated bone loss via inhibiting parathyroid hormone-induced endothelial-to-adipocyte transition in chronic kidney disease rats.Ann Transl Med. 2019 Jul;7(14):312. doi: 10.21037/atm.2019.06.44.
|
| 54 |
Pin1 and secondary hyperparathyroidism of chronic kidney disease: gene polymorphisms and protein levels.Ren Fail. 2017 Nov;39(1):159-165. doi: 10.1080/0886022X.2016.1256310. Epub 2016 Nov 23.
|
| 55 |
RANKL/OPG system regulation by endogenous PTH and PTH1R/ATF4 axis in bone: Implications for bone accrual and strength in growing rats with mild uremia.Cytokine. 2018 Jun;106:19-28. doi: 10.1016/j.cyto.2018.03.002. Epub 2018 Mar 9.
|
| 56 |
iRhom2 promotes lupus nephritis through TNF- and EGFR signaling.J Clin Invest. 2018 Apr 2;128(4):1397-1412. doi: 10.1172/JCI97650. Epub 2018 Mar 5.
|
| 57 |
S100/Calgranulin-mediated inflammation accelerates left ventricular hypertrophy and aortic valve sclerosis in chronic kidney disease in a receptor for advanced glycation end products-dependent manner.Arterioscler Thromb Vasc Biol. 2014 Jul;34(7):1399-411. doi: 10.1161/ATVBAHA.114.303508. Epub 2014 May 22.
|
| 58 |
High prevalence of chronic kidney disease among patients with diabetic foot: A cross-sectional study at a tertiary hospital in China.Nephrology (Carlton). 2020 Feb;25(2):150-155. doi: 10.1111/nep.13596. Epub 2019 May 20.
|
| 59 |
Amelioration of Uremic Toxin Indoxyl Sulfate-Induced Osteoblastic Calcification by SET Domain Containing Lysine Methyltransferase 7/9 Protein.Nephron. 2019;141(4):287-294. doi: 10.1159/000495885. Epub 2019 Feb 15.
|
| 60 |
Review of the efficacy of AST-120 (KREMEZIN()) on renal function in chronic kidney disease patients.Ren Fail. 2019 Nov;41(1):47-56. doi: 10.1080/0886022X.2018.1561376.
|
| 61 |
Vitamin D-regulated osteocytic sclerostin and BMP2 modulate uremic extraskeletal calcification.JCI Insight. 2019 Jul 11;4(13):e126467. doi: 10.1172/jci.insight.126467. eCollection 2019 Jul 11.
|
| 62 |
The Effect of Uremic Solutes on the Organic Cation Transporter 2.J Pharm Sci. 2017 Sep;106(9):2551-2557. doi: 10.1016/j.xphs.2017.04.076. Epub 2017 May 5.
|
| 63 |
Quantitative Translation of Microfluidic Transporter in Vitro Data to in Vivo Reveals Impaired Albumin-Facilitated Indoxyl Sulfate Secretion in Chronic Kidney Disease.Mol Pharm. 2019 Nov 4;16(11):4551-4562. doi: 10.1021/acs.molpharmaceut.9b00681. Epub 2019 Sep 27.
|
| 64 |
A renal-cerebral-peripheral sympathetic reflex mediates insulin resistance in chronic kidney disease.EBioMedicine. 2018 Nov;37:281-293. doi: 10.1016/j.ebiom.2018.10.054. Epub 2018 Nov 11.
|
| 65 |
Urine Trefoil Factors as Prognostic Biomarkers in Chronic Kidney Disease.Biomed Res Int. 2018 Apr 3;2018:3024698. doi: 10.1155/2018/3024698. eCollection 2018.
|
| 66 |
Vitamin D receptor activation raises soluble thrombomodulin levels in chronic kidney disease patients: a double blind, randomized trial.Nephrol Dial Transplant. 2019 May 1;34(5):819-824. doi: 10.1093/ndt/gfy085.
|
| 67 |
Thymosin-4: A key modifier of renal disease.Expert Opin Biol Ther. 2018 Jul;18(sup1):185-192. doi: 10.1080/14712598.2018.1473371. Epub 2018 May 9.
|
| 68 |
Expression of bone-related proteins in vascular calcification and its serum correlations with coronary artery calcification score.J Biol Regul Homeost Agents. 2019 Jan-Feb,;33(1):29-38.
|
| 69 |
Design, synthesis and characterization of novel N-heterocyclic-1-benzyl-1H-benzo[d]imidazole-2-amines as selective TRPC5 inhibitors leading to the identification of the selective compound, AC1903.Bioorg Med Chem Lett. 2019 Jan 15;29(2):155-159. doi: 10.1016/j.bmcl.2018.12.007. Epub 2018 Dec 4.
|
| 70 |
Predictive value of ADAMTS-13 on concealed chronic renal failure in COPD patients.Int J Chron Obstruct Pulmon Dis. 2017 Dec 5;12:3495-3501. doi: 10.2147/COPD.S151983. eCollection 2017.
|
| 71 |
Publisher Correction: Predictors of chronic kidney disease in type 1 diabetes: a longitudinal study from the AMD Annals initiative.Sci Rep. 2018 Apr 12;8(1):5999. doi: 10.1038/s41598-018-23163-2.
|
| 72 |
Chronic kidney disease alters lipid trafficking and inflammatory responses in macrophages: effects of liver X receptor agonism.BMC Nephrol. 2018 Jan 27;19(1):17. doi: 10.1186/s12882-018-0814-8.
|
| 73 |
Greater aortic stiffness is associated with renal dysfunction in participants of the ELSA-Brasil cohort with and without hypertension and diabetes.PLoS One. 2019 Feb 4;14(2):e0210522. doi: 10.1371/journal.pone.0210522. eCollection 2019.
|
| 74 |
Apelin affects the mouse aging urinary peptidome with minimal effects on kidney.Sci Rep. 2019 Jul 23;9(1):10647. doi: 10.1038/s41598-019-47109-4.
|
| 75 |
Associations of Proton-Pump Inhibitors and H2 Receptor Antagonists with Chronic Kidney Disease: A Meta-Analysis.Dig Dis Sci. 2017 Oct;62(10):2821-2827. doi: 10.1007/s10620-017-4725-5. Epub 2017 Aug 23.
|
| 76 |
BMP1 inhibitor UK383,367 attenuates renal fibrosis and inflammation in CKD.Am J Physiol Renal Physiol. 2019 Dec 1;317(6):F1430-F1438. doi: 10.1152/ajprenal.00230.2019. Epub 2019 Sep 23.
|
| 77 |
Polymorphisms of genes involved in lipid metabolism and risk of chronic kidney disease in Japanese - cross-sectional data from the J-MICC study.Lipids Health Dis. 2014 Oct 14;13:162. doi: 10.1186/1476-511X-13-162.
|
| 78 |
Effect of Serum Parathyroid Hormone on Tacrolimus Therapy in Kidney Transplant Patients: A Possible Biomarker for a Tacrolimus Dosage Schedule.Biol Pharm Bull. 2019;42(5):786-791. doi: 10.1248/bpb.b18-00976.
|
| 79 |
DDR1: A major player in renal diseases.Cell Adh Migr. 2018;12(4):299-304. doi: 10.1080/19336918.2018.1441661. Epub 2018 Feb 27.
|
| 80 |
Edoxaban Exerts Antioxidant Effects Through FXa Inhibition and Direct Radical-Scavenging Activity.Int J Mol Sci. 2019 Aug 24;20(17):4140. doi: 10.3390/ijms20174140.
|
| 81 |
Polycystic kidney features of the renal pathology in glycogen storage disease type I: possible evolution to renal neoplasia.J Inherit Metab Dis. 2018 Nov;41(6):955-963. doi: 10.1007/s10545-018-0207-y. Epub 2018 Jun 4.
|
| 82 |
Phenotype-genotype correlation in antenatal and neonatal variants of Bartter syndrome.Nephrol Dial Transplant. 2009 May;24(5):1455-64. doi: 10.1093/ndt/gfn689. Epub 2008 Dec 18.
|
| 83 |
Plasma Levels of Pre1-HDL Are Significantly Elevated in Non-Dialyzed Patients with Advanced Stages of Chronic Kidney Disease.Int J Mol Sci. 2019 Mar 9;20(5):1202. doi: 10.3390/ijms20051202.
|
| 84 |
Emerging role of myostatin and its inhibition in the setting of chronic kidney disease.Kidney Int. 2019 Mar;95(3):506-517. doi: 10.1016/j.kint.2018.10.010. Epub 2018 Dec 28.
|
| 85 |
Genetic association for renal traits among participants of African ancestry reveals new loci for renal function.PLoS Genet. 2011 Sep;7(9):e1002264. doi: 10.1371/journal.pgen.1002264. Epub 2011 Sep 8.
|
| 86 |
Genetic risk variants for membranous nephropathy: extension of and association with other chronic kidney disease aetiologies.Nephrol Dial Transplant. 2017 Feb 1;32(2):325-332. doi: 10.1093/ndt/gfw001. Epub 2016 Feb 4.
|
| 87 |
CCN1 induces adipogenic differentiation of fibro/adipogenic progenitors in a chronic kidney disease model.Biochem Biophys Res Commun. 2019 Dec 3;520(2):385-391. doi: 10.1016/j.bbrc.2019.10.047. Epub 2019 Oct 9.
|
| 88 |
PNPLA3 rs738409 is associated with renal glomerular and tubular injury in NAFLD patients with persistently normal ALT levels.Liver Int. 2020 Jan;40(1):107-119. doi: 10.1111/liv.14251. Epub 2019 Oct 7.
|
| 89 |
The impact of antihypertensive pharmacotherapy on interplay between protein-bound uremic toxin (indoxyl sulfate) and markers of inflammation in patients with chronic kidney disease.Int Urol Nephrol. 2019 Mar;51(3):491-502. doi: 10.1007/s11255-018-02064-3. Epub 2019 Jan 7.
|
| 90 |
SGK1 induces vascular smooth muscle cell calcification through NF-B signaling.J Clin Invest. 2018 Jul 2;128(7):3024-3040. doi: 10.1172/JCI96477. Epub 2018 Jun 11.
|
| 91 |
Elevations in Cortical Porosity Occur Prior to Significant Rise in Serum Parathyroid Hormone in Young Female Mice with Adenine-Induced CKD.Calcif Tissue Int. 2020 Apr;106(4):392-400. doi: 10.1007/s00223-019-00642-w. Epub 2019 Dec 12.
|
| 92 |
Association of genetic variants with chronic kidney disease in Japanese individuals.Clin J Am Soc Nephrol. 2009 May;4(5):883-90. doi: 10.2215/CJN.04350808. Epub 2009 Apr 30.
|
| 93 |
Urotensin II in the development and progression of chronic kidney disease following ?nephrectomy in the rat.Exp Physiol. 2019 Mar;104(3):421-433. doi: 10.1113/EP087366. Epub 2019 Jan 15.
|
| 94 |
Relationship between Xanthine Oxidoreductase Redox and Oxidative Stress among Chronic Kidney Disease Patients.Oxid Med Cell Longev. 2018 Jul 8;2018:9714710. doi: 10.1155/2018/9714710. eCollection 2018.
|
| 95 |
Time to Target Uric Acid to Retard Chronic Kidney Disease Progression.Contrib Nephrol. 2018;192:56-68. doi: 10.1159/000484279. Epub 2018 Jan 23.
|
| 96 |
Circulating miR-421 Targeting Leucocytic Angiotensin Converting Enzyme 2 Is Elevated in Patients with Chronic Kidney Disease.Nephron. 2019;141(1):61-74. doi: 10.1159/000493805. Epub 2018 Oct 16.
|
| 97 |
ATP-citrate lyase is an epigenetic regulator to promote obesity-related kidney injury.FASEB J. 2019 Aug;33(8):9602-9615. doi: 10.1096/fj.201900213R. Epub 2019 May 31.
|
| 98 |
Circulating ADAMs are associated with renal and cardiovascular outcomes in chronic kidney disease patients.Nephrol Dial Transplant. 2020 Jan 1;35(1):130-138. doi: 10.1093/ndt/gfy240.
|
| 99 |
Identification of 13 novel susceptibility loci for early-onset myocardial infarction, hypertension, or chronic kidney disease.Int J Mol Med. 2018 Nov;42(5):2415-2436. doi: 10.3892/ijmm.2018.3852. Epub 2018 Sep 4.
|
| 100 |
Intermedin1-53 attenuates vascular calcification in rats with chronic kidney disease by upregulation of -Klotho.Kidney Int. 2016 Mar;89(3):586-600. doi: 10.1016/j.kint.2015.12.029. Epub 2016 Jan 28.
|
| 101 |
Receptor for advanced glycation end products: a key molecule in the genesis of chronic kidney disease vascular calcification and a potential modulator of sodium phosphate co-transporter PIT-1 expression.Nephrol Dial Transplant. 2019 Dec 1;34(12):2018-2030. doi: 10.1093/ndt/gfz012.
|
| 102 |
Whole-exome resequencing distinguishes cystic kidney diseases from phenocopies in renal ciliopathies.Kidney Int. 2014 Apr;85(4):880-7. doi: 10.1038/ki.2013.450. Epub 2013 Nov 20.
|
| 103 |
The importance of fetuin-A in vascular calcification in children with chronic kidney disease.Adv Clin Exp Med. 2019 Apr;28(4):499-505. doi: 10.17219/acem/82517.
|
| 104 |
Prevalence and correlates of chronic kidney disease (CKD) among ART-naive HIV patients in the Niger-Delta region of Nigeria.Medicine (Baltimore). 2018 Apr;97(16):e0380. doi: 10.1097/MD.0000000000010380.
|
| 105 |
Apelin/APJ system: A critical regulator of vascular smooth muscle cell.J Cell Physiol. 2018 Jul;233(7):5180-5188. doi: 10.1002/jcp.26339. Epub 2018 Jan 23.
|
| 106 |
Apolipoprotein A-IV predicts progression of chronic kidney disease: the mild to moderate kidney disease study.J Am Soc Nephrol. 2006 Feb;17(2):528-36. doi: 10.1681/ASN.2005070733. Epub 2005 Dec 28.
|
| 107 |
Indoxyl sulfate upregulates the cannabinoid type 1 receptor gene via an ATF3/c-Jun complex-mediated signaling pathway in the model of uremic cardiomyopathy.Int J Cardiol. 2018 Feb 1;252:128-135. doi: 10.1016/j.ijcard.2017.11.086. Epub 2017 Dec 2.
|
| 108 |
Recommendations for the use of tolvaptan in autosomal dominant polycystic kidney disease: a position statement on behalf of the ERA-EDTA Working Groups on Inherited Kidney Disorders and European Renal Best Practice.Nephrol Dial Transplant. 2016 Mar;31(3):337-48. doi: 10.1093/ndt/gfv456. Epub 2016 Jan 29.
|
| 109 |
Markers of kidney tubule function and risk of cardiovascular disease events and mortality in the SPRINT trial.Eur Heart J. 2019 Nov 1;40(42):3486-3493. doi: 10.1093/eurheartj/ehz392.
|
| 110 |
Association of the human bradykinin B2 receptor gene with chronic renal failure.Mol Diagn. 2004;8(3):157-61. doi: 10.1007/BF03260059.
|
| 111 |
Incremental effects of diabetes mellitus and chronic kidney disease in medial arterial calcification: Synergistic pathways for peripheral artery disease progression.Vasc Med. 2019 Oct;24(5):383-394. doi: 10.1177/1358863X19842276. Epub 2019 May 15.
|
| 112 |
Inflammation and renal fibrosis: Recent developments on key signaling molecules as potential therapeutic targets.Eur J Pharmacol. 2018 Feb 5;820:65-76. doi: 10.1016/j.ejphar.2017.12.016. Epub 2017 Dec 8.
|
| 113 |
Inflammation induces osteoclast differentiation from peripheral mononuclear cells in chronic kidney disease patients: crosstalk between the immune and bone systems.Nephrol Dial Transplant. 2018 Jan 1;33(1):65-75. doi: 10.1093/ndt/gfx222.
|
| 114 |
High serum soluble CD200 levels in patients with autosomal dominant polycystic kidney disease.J Investig Med. 2017 Apr;65(4):784-786. doi: 10.1136/jim-2016-000326. Epub 2017 Feb 8.
|
| 115 |
Can we predict when to start renal replacement therapy in patients with chronic kidney disease using 6 months of clinical data?.PLoS One. 2018 Oct 4;13(10):e0204586. doi: 10.1371/journal.pone.0204586. eCollection 2018.
|
| 116 |
Implementation of a scalable, web-based, automated clinical decision support risk-prediction tool for chronic kidney disease using C-CDA and application programming interfaces.J Am Med Inform Assoc. 2017 Nov 1;24(6):1111-1115. doi: 10.1093/jamia/ocx065.
|
| 117 |
High levels of urinary complement proteins are associated with chronic renal damage and proximal tubule dysfunction in immunoglobulin A nephropathy.Nephrology (Carlton). 2019 Jul;24(7):703-710. doi: 10.1111/nep.13477. Epub 2019 Apr 23.
|
| 118 |
Chronic renal failure in a boy with classic Bartter's syndrome due to a novel mutation in CLCNKB coding for the chloride channel.Eur J Pediatr. 2009 Sep;168(9):1129-33. doi: 10.1007/s00431-008-0883-y. Epub 2008 Dec 3.
|
| 119 |
Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.J Am Soc Nephrol. 2018 May;29(5):1513-1524. doi: 10.1681/ASN.2017101099. Epub 2018 Mar 15.
|
| 120 |
Over-expressed microRNA-181a reduces glomerular sclerosis and renal tubular epithelial injury in rats with chronic kidney disease via down-regulation of the TLR/NF-B pathway by binding to CRY1.Mol Med. 2018 Sep 18;24(1):49. doi: 10.1186/s10020-018-0045-2.
|
| 121 |
Cardiotrophin-1 opposes renal fibrosis in mice: Potential prevention of chronic kidney disease.Acta Physiol (Oxf). 2019 Jun;226(2):e13247. doi: 10.1111/apha.13247. Epub 2019 Jan 18.
|
| 122 |
In silico identification and screening of CYP24A1 inhibitors: 3D QSAR pharmacophore mapping and molecular dynamics analysis.J Biomol Struct Dyn. 2019 Apr;37(7):1700-1714. doi: 10.1080/07391102.2018.1464958. Epub 2018 May 4.
|
| 123 |
Impairment of the carnitine/organic cation transporter 1-ergothioneine axis is mediated by intestinal transporter dysfunction in chronic kidney disease.Kidney Int. 2017 Dec;92(6):1356-1369. doi: 10.1016/j.kint.2017.04.032. Epub 2017 Jul 26.
|
| 124 |
D-serine, a novel uremic toxin, induces senescence in human renal tubular cells via GCN2 activation.Sci Rep. 2017 Sep 11;7(1):11168. doi: 10.1038/s41598-017-11049-8.
|
| 125 |
Association of gain-of-function EPHX2 polymorphism Lys55Arg with acute kidney injury following cardiac surgery.PLoS One. 2017 May 26;12(5):e0175292. doi: 10.1371/journal.pone.0175292. eCollection 2017.
|
| 126 |
Model-based approach for methoxy polyethylene glycol-epoetin beta drug development in paediatric patients with anaemia of chronic kidney disease.Br J Clin Pharmacol. 2020 Apr;86(4):801-811. doi: 10.1111/bcp.14186. Epub 2020 Jan 21.
|
| 127 |
Peroxidasin and eosinophil peroxidase, but not myeloperoxidase, contribute to renal fibrosis in the murine unilateral ureteral obstruction model.Am J Physiol Renal Physiol. 2019 Feb 1;316(2):F360-F371. doi: 10.1152/ajprenal.00291.2018. Epub 2018 Dec 19.
|
| 128 |
Genomic integration of ERR-HNF1 regulates renal bioenergetics and prevents chronic kidney disease.Proc Natl Acad Sci U S A. 2018 May 22;115(21):E4910-E4919. doi: 10.1073/pnas.1804965115. Epub 2018 May 7.
|
| 129 |
Blood coagulation system in patients with chronic kidney disease: a prospective observational study.BMJ Open. 2017 Jun 1;7(5):e014294. doi: 10.1136/bmjopen-2016-014294.
|
| 130 |
Cardiac Biomarkers and Cardiovascular Outcome in Children with Chronic Kidney Disease.Iran J Kidney Dis. 2019 Mar;13(2):120-128.
|
| 131 |
Chronic Kidney Disease Is Associated with Increased Plasma Levels of Fibroblast Growth Factors 19 and 21.Kidney Blood Press Res. 2019;44(5):1207-1218. doi: 10.1159/000502647. Epub 2019 Oct 15.
|
| 132 |
Variants in genes belonging to the fibroblast growth factor family are associated with lower extremity amputation in non-Hispanic whites: Findings from the chronic renal insufficiency cohort study.Wound Repair Regen. 2016 Jul;24(4):705-11. doi: 10.1111/wrr.12447. Epub 2016 Jun 20.
|
| 133 |
Endogenous Antiangiogenic Factors in Chronic Kidney Disease: Potential Biomarkers of Progression.Int J Mol Sci. 2018 Jun 24;19(7):1859. doi: 10.3390/ijms19071859.
|
| 134 |
FSTL3 is increased in renal dysfunction.Nephrol Dial Transplant. 2017 Oct 1;32(10):1637-1644. doi: 10.1093/ndt/gfw472.
|
| 135 |
The Role of GDF-15 in Heart Failure Patients With Chronic Kidney Disease.Can J Cardiol. 2019 Apr;35(4):462-470. doi: 10.1016/j.cjca.2018.12.027. Epub 2018 Dec 26.
|
| 136 |
Vitamin K Metabolism in a Rat Model of Chronic Kidney Disease.Am J Nephrol. 2017;45(1):4-13. doi: 10.1159/000451068. Epub 2016 Nov 16.
|
| 137 |
DPP-4 inhibition enhanced renal tubular and myocardial GLP-1 receptor expression decreased in CKD with myocardial infarction.BMC Nephrol. 2019 Mar 1;20(1):75. doi: 10.1186/s12882-019-1243-z.
|
| 138 |
Proteomics analysis of blood plasma in HIV-infected patients with chronic kidney disease.Clin Biochem. 2019 Nov;73:90-97. doi: 10.1016/j.clinbiochem.2019.08.006. Epub 2019 Aug 8.
|
| 139 |
Interleukin-19 as a translational indicator of renal injury. Arch Toxicol. 2015 Jan;89(1):101-6.
|
| 140 |
The role of IL-20 in chronic kidney disease and diabetic nephropathy: Pathogenic and therapeutic implications.J Leukoc Biol. 2018 Nov;104(5):919-923. doi: 10.1002/JLB.MR1217-489R. Epub 2018 Jul 12.
|
| 141 |
Immunomodulatory Molecule IRAK-M Balances Macrophage Polarization and Determines Macrophage Responses during Renal Fibrosis.J Immunol. 2017 Aug 15;199(4):1440-1452. doi: 10.4049/jimmunol.1601982. Epub 2017 Jul 12.
|
| 142 |
GSK3-mediated Keap1-independent regulation of Nrf2 antioxidant response: A molecular rheostat of acute kidney injury to chronic kidney disease transition.Redox Biol. 2019 Sep;26:101275. doi: 10.1016/j.redox.2019.101275. Epub 2019 Jul 17.
|
| 143 |
Blockade of endogenous tissue kallikrein aggravates renal injury by enhancing oxidative stress and inhibiting matrix degradation.Am J Physiol Renal Physiol. 2010 Apr;298(4):F1033-40. doi: 10.1152/ajprenal.00518.2009. Epub 2010 Jan 20.
|
| 144 |
Human tissue kallikrein gene delivery attenuates hypertension, renal injury, and cardiac remodeling in chronic renal failure.Kidney Int. 2000 Aug;58(2):730-9. doi: 10.1046/j.1523-1755.2000.00219.x.
|
| 145 |
Plasma kallikrein activates the epithelial sodium channel invitro but is not essential for volume retention in nephrotic mice.Acta Physiol (Oxf). 2018 Sep;224(1):e13060. doi: 10.1111/apha.13060. Epub 2018 Mar 25.
|
| 146 |
Circulating luteinizing hormone receptor inhibitor(s) in boys with chronic renal failure.Kidney Int. 1997 Mar;51(3):777-84. doi: 10.1038/ki.1997.109.
|
| 147 |
Significance of urinary C-megalin excretion in vitamin D metabolism in pre-dialysis CKD patients.Sci Rep. 2019 Feb 18;9(1):2207. doi: 10.1038/s41598-019-38613-8.
|
| 148 |
Tumor necrosis factor superfamily ligand mRNA expression profiles differ between humans and mice during homeostasis and between various murine kidney injuries.J Biomed Sci. 2017 Sep 19;24(1):77. doi: 10.1186/s12929-017-0383-3.
|
| 149 |
Angiotensin II induces kidney inflammatory injury and fibrosis through binding to myeloid differentiation protein-2 (MD2).Sci Rep. 2017 Mar 21;7:44911. doi: 10.1038/srep44911.
|
| 150 |
Performance of urinary kidney injury molecule-1, neutrophil gelatinase-associated lipocalin, and N-acetyl--D-glucosaminidase to predict chronic kidney disease progression and adverse outcomes.Braz J Med Biol Res. 2017 Mar 30;50(5):e6106. doi: 10.1590/1414-431X20176106.
|
| 151 |
Superoxide and hydrogen peroxide counterregulate myogenic contractions in renal afferent arterioles from a mouse model of chronic kidney disease.Kidney Int. 2017 Sep;92(3):625-633. doi: 10.1016/j.kint.2017.02.009. Epub 2017 Apr 7.
|
| 152 |
Exposure to nerve growth factor worsens nephrotoxic effect induced by Cyclosporine A in HK-2 cells. PLoS One. 2013 Nov 7;8(11):e80113. doi: 10.1371/journal.pone.0080113. eCollection 2013.
|
| 153 |
Tubular NOX4 expression decreases in chronic kidney disease but does not modify fibrosis evolution.Redox Biol. 2019 Sep;26:101234. doi: 10.1016/j.redox.2019.101234. Epub 2019 Jun 5.
|
| 154 |
The guanylate cyclase C agonist linaclotide ameliorates the gut-cardio-renal axis in an adenine-induced mouse model of chronic kidney disease.Nephrol Dial Transplant. 2020 Feb 1;35(2):250-264. doi: 10.1093/ndt/gfz126.
|
| 155 |
P2Y12 inhibitors in acute coronary syndrome patients with renal dysfunction: an analysis from the RENAMI and BleeMACS projects.Eur Heart J Cardiovasc Pharmacother. 2020 Jan 1;6(1):31-42. doi: 10.1093/ehjcvp/pvz048.
|
| 156 |
Phospholipase D: A new mediator during high phosphate-induced vascular calcification associated with chronic kidney disease.J Cell Physiol. 2019 Apr;234(4):4825-4839. doi: 10.1002/jcp.27281. Epub 2018 Sep 12.
|
| 157 |
Periostin contributes to renal and cardiac dysfunction in rats with chronic kidney disease: Reduction of PPAR.Biochimie. 2019 May;160:172-182. doi: 10.1016/j.biochi.2019.03.003. Epub 2019 Mar 16.
|
| 158 |
The Ser/Thr kinase p90RSK promotes kidney fibrosis by modulating fibroblast-epithelial crosstalk.J Biol Chem. 2019 Jun 21;294(25):9901-9910. doi: 10.1074/jbc.RA119.007904. Epub 2019 May 10.
|
| 159 |
Serum protease activity in chronic kidney disease patients: The GANI_MED renal cohort.Exp Biol Med (Maywood). 2017 Mar;242(5):554-563. doi: 10.1177/1535370216684040. Epub 2016 Dec 30.
|
| 160 |
Altered expression of intestinal duodenal cytochrome b and divalent metal transporter 1 might be associated with cardio-renal anemia syndrome.Heart Vessels. 2017 Nov;32(11):1410-1414. doi: 10.1007/s00380-017-1013-4. Epub 2017 Jul 1.
|
| 161 |
AT1 Receptor Antagonism Improves Structural, Functional, and Biomechanical Properties in Resistance Arteries in a Rodent Chronic Kidney Disease Model.Am J Hypertens. 2018 May 7;31(6):696-705. doi: 10.1093/ajh/hpy021.
|
| 162 |
Uremic Toxin Indoxyl Sulfate Promotes Proinflammatory Macrophage Activation Via the Interplay of OATP2B1 and Dll4-Notch Signaling.Circulation. 2019 Jan 2;139(1):78-96. doi: 10.1161/CIRCULATIONAHA.118.034588.
|
| 163 |
SLCO4C1 transporter eliminates uremic toxins and attenuates hypertension and renal inflammation. J Am Soc Nephrol. 2009 Dec;20(12):2546-55.
|
| 164 |
Atorvastatin Improves Hepatic Lipid Metabolism and Protects Renal Damage in Adenine-Induced Chronic Kidney Disease in Sprague-Dawley Rats.Biomed Res Int. 2019 Nov 5;2019:8714363. doi: 10.1155/2019/8714363. eCollection 2019.
|
| 165 |
Sphingosine Kinase-2 Deficiency Ameliorates Kidney Fibrosis by Up-Regulating Smad7 in a Mouse Model of Unilateral Ureteral Obstruction.Am J Pathol. 2017 Nov;187(11):2413-2429. doi: 10.1016/j.ajpath.2017.06.017. Epub 2017 Aug 12.
|
| 166 |
Human SA gene Pst1 polymorphism and chronic renal failure: results of the family-based study.Nephrol Dial Transplant. 2001 Feb;16(2):387-90. doi: 10.1093/ndt/16.2.387.
|
| 167 |
The ligand-bound thyroid hormone receptor in macrophages ameliorates kidney injury via inhibition of nuclear factor-B activities.Sci Rep. 2017 Mar 8;7:43960. doi: 10.1038/srep43960.
|
| 168 |
Association Between a Polymorphism in MBOAT7 and Chronic Kidney Disease in Patients With Biopsy-Confirmed Nonalcoholic Fatty Liver Disease.Clin Gastroenterol Hepatol. 2020 Nov;18(12):2837-2839.e2. doi: 10.1016/j.cgh.2019.09.017. Epub 2019 Sep 20.
|
| 169 |
Soluble TWEAK and atheromatosis progression in patients with chronic kidney disease.Atherosclerosis. 2017 May;260:130-137. doi: 10.1016/j.atherosclerosis.2017.03.043. Epub 2017 Mar 31.
|
| 170 |
Elevated ecto-5'-nucleotidase-mediated increased renal adenosine signaling via A2B adenosine receptor contributes to chronic hypertension.Circ Res. 2013 May 24;112(11):1466-78. doi: 10.1161/CIRCRESAHA.111.300166. Epub 2013 Apr 12.
|
| 171 |
Association of genetic variants with chronic kidney disease in Japanese individuals with type 2 diabetes mellitus.Int J Mol Med. 2009 Apr;23(4):529-37. doi: 10.3892/ijmm_00000161.
|
| 172 |
New loci associated with kidney function and chronic kidney disease.Nat Genet. 2010 May;42(5):376-84. doi: 10.1038/ng.568. Epub 2010 Apr 11.
|
| 173 |
CD248+ stromal cells are associated with progressive chronic kidney disease.Kidney Int. 2011 Jul;80(2):199-207. doi: 10.1038/ki.2011.103. Epub 2011 Apr 13.
|
| 174 |
Association of dopaminergic pathway gene polymorphisms with chronic renal insufficiency among Asian Indians with type-2 diabetes.BMC Genet. 2008 Mar 22;9:26. doi: 10.1186/1471-2156-9-26.
|
| 175 |
Serum Glutaredoxin Activity as a Marker of Oxidative Stress in Chronic Kidney Disease: A Pilot Study.Nephron. 2018;140(4):249-256. doi: 10.1159/000492500. Epub 2018 Sep 25.
|
| 176 |
Hepatocyte nuclear factors as possible C-reactive protein transcriptional inducer in the liver and white adipose tissue of rats with experimental chronic renal failure.Mol Cell Biochem. 2018 Sep;446(1-2):11-23. doi: 10.1007/s11010-018-3268-1. Epub 2018 Jan 12.
|
| 177 |
Association of genetic variants with chronic kidney disease in individuals with different lipid profiles.Int J Mol Med. 2009 Aug;24(2):233-46. doi: 10.3892/ijmm_00000226.
|
| 178 |
CKD in MYH9-related disorders.Am J Kidney Dis. 2009 Oct;54(4):732-40. doi: 10.1053/j.ajkd.2009.06.023. Epub 2009 Sep 2.
|
| 179 |
Changes in FGF-23, Neutrophil/Platelet Activation Markers, and Angiogenin in Advanced Chronic Kidney Disease and Their Effect on Arterial Stiffness.Kidney Blood Press Res. 2019;44(5):1166-1178. doi: 10.1159/000502526. Epub 2019 Sep 25.
|
| 180 |
Association of gene polymorphisms with chronic kidney disease in high- or low-risk subjects defined by conventional risk factors.Int J Mol Med. 2009 Jun;23(6):785-92. doi: 10.3892/ijmm_00000193.
|
| 181 |
Common -globin variants modify hematologic and other clinical phenotypes in sickle cell trait and disease.PLoS Genet. 2018 Mar 28;14(3):e1007293. doi: 10.1371/journal.pgen.1007293. eCollection 2018 Mar.
|
| 182 |
Efficacy of different hemodialysis methods on dendritic cell marker CD40 and CD80 and platelet activation marker CD62P and P10 in patients with chronic renal failure.J Clin Lab Anal. 2019 Mar;33(3):e22713. doi: 10.1002/jcla.22713. Epub 2018 Nov 29.
|
| 183 |
Signal regulatory protein alpha initiates cachexia through muscle to adipose tissue crosstalk.J Cachexia Sarcopenia Muscle. 2019 Dec;10(6):1210-1227. doi: 10.1002/jcsm.12459. Epub 2019 Sep 11.
|
| 184 |
Genetics of serum urate concentrations and gout in a high-risk population, patients with chronic kidney disease.Sci Rep. 2018 Sep 4;8(1):13184. doi: 10.1038/s41598-018-31282-z.
|
| 185 |
Tenapanor: First Approval.Drugs. 2019 Nov;79(17):1897-1903. doi: 10.1007/s40265-019-01215-9.
|
| 186 |
High Mobility Group Box Protein-1 correlates with renal function in chronic kidney disease (CKD).Mol Med. 2008 Mar-Apr;14(3-4):109-15. doi: 10.2119/2007-00107.Bruchfeld.
|
| 187 |
Transketolase Activity but not Thiamine Membrane Transport Change in Response to Hyperglycaemia and Kidney Dysfunction.Exp Clin Endocrinol Diabetes. 2018 Apr;126(4):255-262. doi: 10.1055/s-0043-115009. Epub 2017 Sep 26.
|
| 188 |
Calcium-dependent expression of transient receptor potential canonical type 3 channels in patients with chronic kidney disease.Arch Biochem Biophys. 2011 Oct;514(1-2):44-9. doi: 10.1016/j.abb.2011.07.011. Epub 2011 Jul 23.
|
| 189 |
Renal Fibrosis, Immune Cell Infiltration and Changes of TRPC Channel Expression after Unilateral Ureteral Obstruction in Trpc6-/- Mice.Cell Physiol Biochem. 2019;52(6):1484-1502. doi: 10.33594/000000103.
|
| 190 |
Dual effect of chemokine CCL7/MCP-3 in the development of renal tubulointerstitial fibrosis.Biochem Biophys Res Commun. 2013 Aug 23;438(2):257-63. doi: 10.1016/j.bbrc.2013.07.025. Epub 2013 Jul 19.
|
| 191 |
Oxidative stress pathway genes and chronic renal insufficiency in Asian Indians with Type 2 diabetes.J Diabetes Complications. 2009 Mar-Apr;23(2):102-11. doi: 10.1016/j.jdiacomp.2007.10.003. Epub 2008 Apr 16.
|
| 192 |
Clinical and genetic factors influencing acenocoumarol dosing: a cross-sectional study.Blood Coagul Fibrinolysis. 2018 Sep;29(6):496-500. doi: 10.1097/MBC.0000000000000746.
|
| 193 |
Phosphate-dependent FGF23 secretion is modulated by PiT2/Slc20a2.Mol Metab. 2018 May;11:197-204. doi: 10.1016/j.molmet.2018.02.007. Epub 2018 Feb 26.
|
| 194 |
Low renin-angiotensin system activity gene polymorphism and dysplasia associated with posterior urethral valves.J Urol. 2005 Aug;174(2):713-7. doi: 10.1097/01.ju.0000164739.13408.e2.
|
| 195 |
The ABCC6 Transporter as a Paradigm for Networking from an Orphan Disease to Complex Disorders.Biomed Res Int. 2015;2015:648569. doi: 10.1155/2015/648569. Epub 2015 Aug 18.
|
| 196 |
Tubular iron deposition and iron handling proteins in human healthy kidney and chronic kidney disease.Sci Rep. 2018 Jun 19;8(1):9353. doi: 10.1038/s41598-018-27107-8.
|
| 197 |
An integrative study of the genetic, social and environmental determinants of chronic kidney disease characterized by tubulointerstitial damages in the North Central Region of Sri Lanka.J Occup Health. 2014;56(1):28-38. doi: 10.1539/joh.13-0172-oa. Epub 2013 Dec 18.
|
| 198 |
Sodium-dependent phosphate cotransporters and phosphate-induced calcification of vascular smooth muscle cells: redundant roles for PiT-1 and PiT-2.Arterioscler Thromb Vasc Biol. 2013 Nov;33(11):2625-32. doi: 10.1161/ATVBAHA.113.302249. Epub 2013 Aug 22.
|
| 199 |
Use of Physiologically Based Pharmacokinetic Modeling to Evaluate the Effect of Chronic Kidney Disease on the Disposition of Hepatic CYP2C8 and OATP1B Drug Substrates.Clin Pharmacol Ther. 2019 Mar;105(3):719-729. doi: 10.1002/cpt.1205. Epub 2018 Oct 26.
|
| 200 |
Dimethylarginine Dimethylaminohydrolase 1 Deficiency Induces the Epithelial to Mesenchymal Transition in Renal Proximal Tubular Epithelial Cells and Exacerbates Kidney Damage in Aged and Diabetic Mice.Antioxid Redox Signal. 2017 Dec 1;27(16):1347-1360. doi: 10.1089/ars.2017.7022. Epub 2017 Jul 7.
|
| 201 |
Chronic kidney disease induces left ventricular overexpression of the pro-hypertrophic microRNA-212.Sci Rep. 2019 Feb 4;9(1):1302. doi: 10.1038/s41598-018-37690-5.
|
| 202 |
Proteomic analysis of heart failure hospitalization among patients with chronic kidney disease: The Heart and Soul Study.PLoS One. 2018 Dec 17;13(12):e0208042. doi: 10.1371/journal.pone.0208042. eCollection 2018.
|
| 203 |
Candidate gene association study of coronary artery calcification in chronic kidney disease: findings from the CRIC study (Chronic Renal Insufficiency Cohort).J Am Coll Cardiol. 2013 Aug 27;62(9):789-98. doi: 10.1016/j.jacc.2013.01.103. Epub 2013 May 30.
|
| 204 |
Identification of dicarbonyl and L-xylulose reductase as a therapeutic target in human chronic kidney disease.JCI Insight. 2019 Jun 20;4(12):e128120. doi: 10.1172/jci.insight.128120. eCollection 2019 Jun 20.
|
| 205 |
Association of FMO3 Variants and Trimethylamine N-Oxide Concentration, Disease Progression, and Mortality in CKD Patients.PLoS One. 2016 Aug 11;11(8):e0161074. doi: 10.1371/journal.pone.0161074. eCollection 2016.
|
| 206 |
Genetic-Variation-Driven Gene-Expression Changes Highlight Genes with Important Functions for Kidney Disease.Am J Hum Genet. 2017 Jun 1;100(6):940-953. doi: 10.1016/j.ajhg.2017.05.004.
|
| 207 |
Metallothionein MT2A A-5G Polymorphism as a Risk Factor for Chronic Kidney Disease and Diabetes: Cross-Sectional and Cohort Studies.Toxicol Sci. 2016 Jul;152(1):181-93. doi: 10.1093/toxsci/kfw080. Epub 2016 Apr 27.
|
| 208 |
Subclinical hypothyroidism and the risk of chronic kidney disease in T2D subjects: A case-control and dose-response analysis.Medicine (Baltimore). 2017 Apr;96(15):e6519. doi: 10.1097/MD.0000000000006519.
|
| 209 |
Association analysis of ADPRT1, AKR1B1, RAGE, GFPT2 and PAI-1 gene polymorphisms with chronic renal insufficiency among Asian Indians with type-2 diabetes.BMC Med Genet. 2010 Mar 31;11:52. doi: 10.1186/1471-2350-11-52.
|
| 210 |
KDOQI US Commentary on the 2017 ACC/AHA Hypertension Guideline.Am J Kidney Dis. 2019 Apr;73(4):437-458. doi: 10.1053/j.ajkd.2019.01.007.
|
| 211 |
Association of candidate gene polymorphisms with chronic kidney disease in Japanese individuals with hypertension.Hypertens Res. 2009 May;32(5):411-8. doi: 10.1038/hr.2009.22. Epub 2009 Mar 13.
|
| 212 |
Aryl hydrocarbon receptor is activated in patients and mice with chronic kidney disease.Kidney Int. 2018 Apr;93(4):986-999. doi: 10.1016/j.kint.2017.11.010. Epub 2018 Feb 1.
|
| 213 |
ALPK1 regulates streptozotocin-induced nephropathy through CCL2 and CCL5 expressions.J Cell Mol Med. 2019 Nov;23(11):7699-7708. doi: 10.1111/jcmm.14643. Epub 2019 Sep 26.
|
| 214 |
Integrin linked kinase regulates the transcription of AQP2 by NFATC3.Biochim Biophys Acta Gene Regul Mech. 2017 Sep;1860(9):922-935. doi: 10.1016/j.bbagrm.2017.07.006. Epub 2017 Jul 20.
|
| 215 |
Comparison of readout-segmented and conventional single-shot for echo-planar diffusion-weighted imaging in the assessment of kidney interstitial fibrosis.J Magn Reson Imaging. 2017 Dec;46(6):1631-1640. doi: 10.1002/jmri.25687. Epub 2017 Mar 10.
|
| 216 |
Uraemia-induced immune senescence and clinical outcomes in chronic kidney disease patients.Nephrol Dial Transplant. 2020 Apr 1;35(4):624-632. doi: 10.1093/ndt/gfy276.
|
| 217 |
Genome-Wide Association Study of Renal Function Traits: Results from the Japan Multi-Institutional Collaborative Cohort Study.Am J Nephrol. 2018;47(5):304-316. doi: 10.1159/000488946. Epub 2018 May 18.
|
| 218 |
Vitamin K role in mineral and bone disorder of chronic kidney disease.Clin Chim Acta. 2020 Mar;502:66-72. doi: 10.1016/j.cca.2019.11.040. Epub 2019 Dec 11.
|
| 219 |
Early Postoperative Neutrophil Gelatinase-Associated Lipocalin Predicts the Development of Chronic Kidney Disease After Liver Transplantation.Transplantation. 2018 May;102(5):809-815. doi: 10.1097/TP.0000000000002075.
|
| 220 |
Serum Resistin, Adenylate Cyclase-Associated Protein 1 Gene Expression, and Carotid Intima-Media Thickness in Patients with End-Stage Renal Disease and Healthy Controls.Cardiorenal Med. 2020;10(1):51-60. doi: 10.1159/000503416. Epub 2019 Nov 13.
|
| 221 |
Difference in SBP between arms is a predictor of chronic kidney disease development in the general Korean population.J Hypertens. 2019 Apr;37(4):790-794. doi: 10.1097/HJH.0000000000001931.
|
| 222 |
Chromogranin A pathway: from pathogenic molecule to renal disease.J Hypertens. 2020 Mar;38(3):456-466. doi: 10.1097/HJH.0000000000002295.
|
| 223 |
ClC-5 alleviates renal fibrosis in unilateral ureteral obstruction mice.Hum Cell. 2019 Jul;32(3):297-305. doi: 10.1007/s13577-019-00253-5. Epub 2019 May 3.
|
| 224 |
Preoperative chronic kidney disease predicts poor oncological outcomes after radical cystectomy in patients with muscle-invasive bladder cancer.Oncotarget. 2017 May 29;8(37):61404-61414. doi: 10.18632/oncotarget.18248. eCollection 2017 Sep 22.
|
| 225 |
Getting a Notch closer to renal dysfunction: activated Notch suppresses expression of the adaptor protein Disabled-2 in tubular epithelial cells.FASEB J. 2019 Jan;33(1):821-832. doi: 10.1096/fj.201800392RR. Epub 2018 Jul 27.
|
| 226 |
Validity of self blood pressure measurement in the control of the hypertensive patient: factors involved.BMC Cardiovasc Disord. 2019 Jul 17;19(1):171. doi: 10.1186/s12872-019-1145-9.
|
| 227 |
High serum levels of p,p'-DDE are associated with an accelerated decline in GFR during 10years follow-up.Sci Total Environ. 2018 Dec 10;644:371-374. doi: 10.1016/j.scitotenv.2018.07.020. Epub 2018 Jul 5.
|
| 228 |
Protective effects of Salvia miltiorrhiza on adenine-induced chronic renal failure by regulating the metabolic profiling and modulating the NADPH oxidase/ROS/ERK and TGF-/Smad signaling pathways.J Ethnopharmacol. 2018 Feb 15;212:153-165. doi: 10.1016/j.jep.2017.09.021. Epub 2017 Oct 12.
|
| 229 |
Increased FGF23 protects against detrimental cardio-renal consequences during elevated blood phosphate in CKD.JCI Insight. 2019 Feb 21;4(4):e123817. doi: 10.1172/jci.insight.123817. eCollection 2019 Feb 21.
|
| 230 |
Bromodomain and Extraterminal Proteins as Novel Epigenetic Targets for Renal Diseases.Front Pharmacol. 2019 Nov 8;10:1315. doi: 10.3389/fphar.2019.01315. eCollection 2019.
|
| 231 |
Analysis of chronic kidney disease staging with different estimated glomerular filtration rate equations in Chinese centenarians.Chin Med J (Engl). 2019 Mar 5;132(5):512-518. doi: 10.1097/CM9.0000000000000079.
|
| 232 |
Liver stiffness assessed by transient elastography as a potential indicator of chronic kidney disease in patients with nonalcoholic fatty liver disease.J Clin Lab Anal. 2019 Feb;33(2):e22657. doi: 10.1002/jcla.22657. Epub 2018 Sep 21.
|
| 233 |
Arterial tissue transcriptional profiles associate with tissue remodeling and cardiovascular phenotype in children with end-stage kidney disease.Sci Rep. 2019 Jul 16;9(1):10316. doi: 10.1038/s41598-019-46805-5.
|
| 234 |
Effect of achieved hemoglobin level on renal outcome in non-dialysis chronic kidney disease (CKD) patients receiving epoetin beta pegol: MIRcerA CLinical Evidence on Renal Survival in CKD patients with renal anemia (MIRACLE-CKD Study).Clin Exp Nephrol. 2019 Mar;23(3):349-361. doi: 10.1007/s10157-018-1649-0. Epub 2018 Oct 5.
|
| 235 |
A risk prediction model for renal damage in a hypertensive Chinese Han population.Clin Exp Hypertens. 2019;41(6):552-557. doi: 10.1080/10641963.2018.1523913. Epub 2018 Oct 9.
|
| 236 |
Urotensin II Induces Mice Skeletal Muscle Atrophy Associated with Enhanced Autophagy and Inhibited Irisin Precursor (Fibronectin Type III Domain Containing 5) Expression in Chronic Renal Failure.Kidney Blood Press Res. 2019;44(4):479-495. doi: 10.1159/000499880. Epub 2019 Jun 25.
|
| 237 |
Identification of nuclear localization, DNA binding, and transactivating mechanisms of Kruppel-like zinc finger protein Gli-similar 2 (Glis2).J Biol Chem. 2011 Feb 11;286(6):4749-59. doi: 10.1074/jbc.M110.165951. Epub 2010 Dec 2.
|
| 238 |
Expression and clinical value of gastrin-releasing peptide precursor in nephropathy and chronic kidney disease.Nephrology (Carlton). 2020 May;25(5):398-405. doi: 10.1111/nep.13642. Epub 2019 Aug 29.
|
| 239 |
Mutational screening of inverted formin 2 in adult-onset focal segmental glomerulosclerosis or minimal change patients from the Czech Republic.BMC Med Genet. 2018 Aug 20;19(1):147. doi: 10.1186/s12881-018-0667-9.
|
| 240 |
Krppel-like Factor 15: A Potential Therapeutic Target For Kidney Disease.Int J Biol Sci. 2019 Jul 21;15(9):1955-1961. doi: 10.7150/ijbs.34838. eCollection 2019.
|
| 241 |
Prevalence and organ distribution of leukocyte chemotactic factor 2 amyloidosis (ALECT2) among decedents in New Mexico.Amyloid. 2016 Jun;23(2):119-23. doi: 10.3109/13506129.2016.1145110. Epub 2016 Feb 25.
|
| 242 |
Arterial calcification: a tumor necrosis factor-alpha mediated vascular Wnt-opathy.Transl Res. 2008 May;151(5):233-9. doi: 10.1016/j.trsl.2007.12.005. Epub 2008 Jan 22.
|
| 243 |
Dietary Fermentable Fibers Attenuate Chronic Kidney Disease in Mice by Protecting the Intestinal Barrier.J Nutr. 2018 Apr 1;148(4):552-561. doi: 10.1093/jn/nxy008.
|
| 244 |
TUDCA-treated chronic kidney disease-derived hMSCs improve therapeutic efficacy in ischemic disease via PrP(C).Redox Biol. 2019 Apr;22:101144. doi: 10.1016/j.redox.2019.101144. Epub 2019 Feb 16.
|
| 245 |
Peroxisome Proliferator-Activated Receptor- Coactivator-1 Inhibits Vascular Calcification Through Sirtuin 3-Mediated Reduction of Mitochondrial Oxidative Stress.Antioxid Redox Signal. 2019 Jul 1;31(1):75-91. doi: 10.1089/ars.2018.7620. Epub 2019 Apr 2.
|
| 246 |
Functional Prediction of Chronic Kidney Disease Susceptibility Gene PRKAG2 by Comprehensively Bioinformatics Analysis.Front Genet. 2018 Dec 3;9:573. doi: 10.3389/fgene.2018.00573. eCollection 2018.
|
| 247 |
Chemerin inhibits vascular calcification through ChemR23 and is associated with lower coronary calcium in chronic kidney disease.J Intern Med. 2019 Oct;286(4):449-457. doi: 10.1111/joim.12940. Epub 2019 Jul 7.
|
| 248 |
Low-dose hydralazine prevents fibrosis in a murine model of acute kidney injury-to-chronic kidney disease progression.Kidney Int. 2017 Jan;91(1):157-176. doi: 10.1016/j.kint.2016.07.042. Epub 2016 Sep 28.
|
| 249 |
Mechanisms of Protective Effects of SGLT2 Inhibitors in Cardiovascular Disease and Renal Dysfunction.Curr Top Med Chem. 2019;19(20):1818-1849. doi: 10.2174/1568026619666190828161409.
|
| 250 |
Long-term blood pressure variability and development of chronic kidney disease in type 2 diabetes.J Hypertens. 2019 Apr;37(4):805-813. doi: 10.1097/HJH.0000000000001950.
|
| 251 |
Shroom3 contributes to the maintenance of the glomerular filtration barrier integrity.Genome Res. 2015 Jan;25(1):57-65. doi: 10.1101/gr.182881.114. Epub 2014 Oct 1.
|
| 252 |
Febuxostat inhibits TGF?induced epithelialmesenchymal transition via downregulation of USAG? expression in MadinDarby canine kidney cells invitro.Mol Med Rep. 2019 Mar;19(3):1694-1704. doi: 10.3892/mmr.2019.9806. Epub 2019 Jan 2.
|
| 253 |
Effect of Omega-3 Fatty Acid on STAMP2 Expression in the Heart and Kidney of 5/6 Nephrectomy Rat Model.Mar Drugs. 2018 Oct 23;16(11):398. doi: 10.3390/md16110398.
|
| 254 |
Economic Issues of Chronic Kidney Disease and End-Stage Renal Disease.Contrib Nephrol. 2019;198:87-93. doi: 10.1159/000496533. Epub 2019 Apr 16.
|
| 255 |
A Mendelian Randomization-Based Approach to Identify Early and Sensitive Diagnostic Biomarkers of Disease.Clin Chem. 2019 Mar;65(3):427-436. doi: 10.1373/clinchem.2018.291104. Epub 2018 Oct 18.
|
| 256 |
Associations between genetic risk variants for kidney diseases and kidney disease etiology.Sci Rep. 2017 Oct 24;7(1):13944. doi: 10.1038/s41598-017-13356-6.
|
| 257 |
Role of Alstrm syndrome 1 in the regulation of blood pressure and renal function.JCI Insight. 2018 Nov 2;3(21):e95076. doi: 10.1172/jci.insight.95076.
|
| 258 |
Circulating 25-hydroxy vitamin D correlates with serum level of anti-Mllerian hormone in male patients with chronic kidney disease.Andrologia. 2018 Feb 14. doi: 10.1111/and.12972. Online ahead of print.
|
| 259 |
AQP5 promotes hepatocellular carcinoma metastasis via NF-B-regulated epithelial-mesenchymal transition.Biochem Biophys Res Commun. 2017 Aug 19;490(2):343-348. doi: 10.1016/j.bbrc.2017.06.046. Epub 2017 Jun 12.
|
| 260 |
Association of genetic variants with dyslipidemia and chronic kidney disease in a longitudinal population-based genetic epidemiological study.Int J Mol Med. 2015 May;35(5):1290-300. doi: 10.3892/ijmm.2015.2152. Epub 2015 Mar 20.
|
| 261 |
Genetic loci associated with renal function measures and chronic kidney disease in children: the Pediatric Investigation for Genetic Factors Linked with Renal Progression Consortium.Nephrol Dial Transplant. 2016 Feb;31(2):262-9. doi: 10.1093/ndt/gfv342. Epub 2015 Sep 28.
|
| 262 |
Obesity and chronic kidney disease progression-the role of a new adipocytokine: C1q/tumour necrosis factor-related protein-1.Clin Kidney J. 2018 Oct 11;12(3):420-426. doi: 10.1093/ckj/sfy095. eCollection 2019 Jun.
|
| 263 |
Identification of the first large deletion in the CLDN16 gene in a patient with FHHNC and late-onset of chronic kidney disease: case report.BMC Nephrol. 2015 Jul 2;16:92. doi: 10.1186/s12882-015-0079-4.
|
| 264 |
The role of molecular genetics in diagnosing familial hematuria(s).Pediatr Nephrol. 2012 Aug;27(8):1221-31. doi: 10.1007/s00467-011-1935-5. Epub 2011 Jun 19.
|
| 265 |
A novel Cys1638Tyr NC1 domain substitution in alpha5(IV) collagen causes Alport syndrome with late onset renal failure without hearing loss or eye abnormalities.Nephrol Dial Transplant. 2007 May;22(5):1338-46. doi: 10.1093/ndt/gfl793. Epub 2007 Feb 3.
|
| 266 |
Follow-up results of patients with ADCK4 mutations and the efficacy of CoQ10 treatment.Pediatr Nephrol. 2017 Aug;32(8):1369-1375. doi: 10.1007/s00467-017-3634-3. Epub 2017 Mar 24.
|
| 267 |
Systemic inflammation is associated with exaggerated skeletal muscle protein catabolism in maintenance hemodialysis patients.JCI Insight. 2017 Nov 16;2(22):e95185. doi: 10.1172/jci.insight.95185. eCollection 2017 Nov 16.
|
| 268 |
Fractional excretion as a new marker of tubular damage in children with chronic kidney disease.Clin Chim Acta. 2018 May;480:99-106. doi: 10.1016/j.cca.2018.02.001. Epub 2018 Feb 6.
|
| 269 |
NLRP3 inflammasome inhibition attenuates cisplatin-induced renal fibrosis by decreasing oxidative stress and inflammation.Exp Cell Res. 2019 Oct 1;383(1):111488. doi: 10.1016/j.yexcr.2019.07.001. Epub 2019 Jul 2.
|
| 270 |
Advanced glycation end products in the pathogenesis of chronic kidney disease.Kidney Int. 2018 Apr;93(4):803-813. doi: 10.1016/j.kint.2017.11.034. Epub 2018 Feb 22.
|
| 271 |
A novel SLC4A1 variant in an autosomal dominant distal renal tubular acidosis family with a severe phenotype.Endocrine. 2010 Jun;37(3):473-8. doi: 10.1007/s12020-010-9340-6. Epub 2010 Apr 17.
|
| 272 |
Polymorphisms in the non-muscle myosin heavy chain gene (MYH9) are associated with lower glomerular filtration rate in mixed ancestry diabetic subjects from South Africa.PLoS One. 2012;7(12):e52529. doi: 10.1371/journal.pone.0052529. Epub 2012 Dec 20.
|
| 273 |
Long-term renal outcome in children with OCRL mutations: retrospective analysis of a large international cohort.Nephrol Dial Transplant. 2018 Jan 1;33(1):85-94. doi: 10.1093/ndt/gfw350.
|
| 274 |
Proenkephalin and risk of developing chronic kidney disease: the Prevention of Renal and Vascular End-stage Disease study.Biomarkers. 2018 Jul;23(5):474-482. doi: 10.1080/1354750X.2018.1443514. Epub 2018 Mar 8.
|
| 275 |
Alternative splicing events is not a key event for gene expression regulation in uremia.PLoS One. 2013 Dec 16;8(12):e82702. doi: 10.1371/journal.pone.0082702. eCollection 2013.
|
| 276 |
Nucleotide-Binding Oligomerization Domain-Like Receptor Protein 3 Deficiency in Vascular Smooth Muscle Cells Prevents Arteriovenous Fistula Failure Despite Chronic Kidney Disease.J Am Heart Assoc. 2019 Jan 8;8(1):e011211. doi: 10.1161/JAHA.118.011211.
|
| 277 |
You-Gui-Yin improved the reproductive dysfunction of male rats with chronic kidney disease via regulating the HIF1-STAT5 pathway.J Ethnopharmacol. 2020 Jan 10;246:112240. doi: 10.1016/j.jep.2019.112240. Epub 2019 Sep 14.
|
| 278 |
RBM10-TFE3 renal cell carcinoma characterised by paracentric inversion with consistent closely split signals in break-apart fluorescence in-situ hybridisation: study of 10 cases and a literature review.Histopathology. 2019 Aug;75(2):254-265. doi: 10.1111/his.13866. Epub 2019 Jun 25.
|
| 279 |
A tubulointerstitial nephritis antigen gene defect causes childhood-onset chronic renal failure.Pediatr Nephrol. 2010 Jul;25(7):1349-53. doi: 10.1007/s00467-010-1463-8. Epub 2010 Feb 16.
|
| 280 |
Long-noncoding RNA Atrolnc-1 promotes muscle wasting in mice with chronic kidney disease.J Cachexia Sarcopenia Muscle. 2018 Oct;9(5):962-974. doi: 10.1002/jcsm.12321. Epub 2018 Jul 24.
|
| 281 |
Impact of serum albumin levels on long-term outcomes in patients undergoing percutaneous coronary intervention.Heart Vessels. 2017 Sep;32(9):1085-1092. doi: 10.1007/s00380-017-0981-8. Epub 2017 Apr 20.
|
| 282 |
The Atypical Chemokine Receptor 2 Limits Progressive Fibrosis after Acute Ischemic Kidney Injury.Am J Pathol. 2019 Feb;189(2):231-247. doi: 10.1016/j.ajpath.2018.09.016. Epub 2018 Nov 16.
|
| 283 |
Dietary supplementation with ketoacids protects against CKD-induced oxidative damage and mitochondrial dysfunction in skeletal muscle of 5/6 nephrectomised rats.Skelet Muscle. 2018 May 31;8(1):18. doi: 10.1186/s13395-018-0164-z.
|
| 284 |
Descriptive Study of Aneurysmal and Nonaneurysmal Subarachnoid Hemorrhage and the Role of Confirmative Digital Subtraction Angiography in Patients with Nonaneurysmal Subarachnoid in Puerto Rico.World Neurosurg. 2020 Feb;134:e481-e486. doi: 10.1016/j.wneu.2019.10.104. Epub 2019 Oct 28.
|
| 285 |
L-Homoarginine and its AGXT2-metabolite GOCA in chronic kidney disease as markers for clinical status and prognosis.Amino Acids. 2018 Oct;50(10):1347-1356. doi: 10.1007/s00726-018-2610-y. Epub 2018 Jul 7.
|
| 286 |
Mitsugumin 53 promotes mitochondrial autophagy through regulating Ambra1 expression in C2C12 myoblast cells.Cell Biol Int. 2019 Mar;43(3):290-298. doi: 10.1002/cbin.11097. Epub 2019 Feb 7.
|
| 287 |
Drug disposition model of radiolabeled etelcalcetide in patients with chronic kidney disease and secondary hyperparathyroidism on hemodialysis.J Pharmacokinet Pharmacodyn. 2017 Feb;44(1):43-53. doi: 10.1007/s10928-016-9503-z. Epub 2017 Jan 6.
|
| 288 |
Apolipoprotein M in patients with chronic kidney disease.Atherosclerosis. 2018 Aug;275:304-311. doi: 10.1016/j.atherosclerosis.2018.06.815. Epub 2018 Jun 15.
|
| 289 |
Aquaporin 11 rs2276415 variant and progression of chronic kidney disease.Nephrol Dial Transplant. 2019 Jun 1;34(6):970-973. doi: 10.1093/ndt/gfy219.
|
| 290 |
Branched-chain amino acids in health and disease: metabolism, alterations in blood plasma, and as supplements.Nutr Metab (Lond). 2018 May 3;15:33. doi: 10.1186/s12986-018-0271-1. eCollection 2018.
|
| 291 |
Identification of C21orf59 and ATG2A as novel determinants of renal function-related traits in Japanese by exome-wide association studies.Oncotarget. 2017 Jul 11;8(28):45259-45273. doi: 10.18632/oncotarget.16696.
|
| 292 |
Intracellular calcium increases in vascular smooth muscle cells with progression of chronic kidney disease in a rat model.Nephrol Dial Transplant. 2017 Mar 1;32(3):450-458. doi: 10.1093/ndt/gfw274.
|
| 293 |
(Pro)renin Receptor Blockade Ameliorates Heart Failure Caused by Chronic Kidney Disease.J Card Fail. 2019 Apr;25(4):286-300. doi: 10.1016/j.cardfail.2019.02.009. Epub 2019 Feb 13.
|
| 294 |
Association between kidney function and genetic polymorphisms in atherosclerotic and chronic kidney diseases: A cross-sectional study in Japanese male workers.PLoS One. 2017 Oct 10;12(10):e0185476. doi: 10.1371/journal.pone.0185476. eCollection 2017.
|
| 295 |
The cartonectin levels at different stages of chronic kidney disease and related factors.Ren Fail. 2019 Feb 7;41(1):42-46. doi: 10.1080/0886022X.2018.1561373. eCollection 2019.
|
| 296 |
HCC-1, a novel chemokine from human plasma.J Exp Med. 1996 Jan 1;183(1):295-9. doi: 10.1084/jem.183.1.295.
|
| 297 |
The CDK9-cyclin T1 complex mediates saturated fatty acid-induced vascular calcification by inducing expression of the transcription factor CHOP.J Biol Chem. 2018 Nov 2;293(44):17008-17020. doi: 10.1074/jbc.RA118.004706. Epub 2018 Sep 12.
|
| 298 |
Mutations in six nephrosis genes delineate a pathogenic pathway amenable to treatment. Nat Commun. 2018 May 17;9(1):1960. doi: 10.1038/s41467-018-04193-w.
|
| 299 |
Elevated MIF-2 levels predict mortality in critically ill patients.J Crit Care. 2017 Aug;40:52-57. doi: 10.1016/j.jcrc.2017.03.012. Epub 2017 Mar 16.
|
| 300 |
Revised Equations to Estimate Glomerular Filtration Rate from Serum Creatinine and Cystatin C in China.Kidney Blood Press Res. 2019;44(4):553-564. doi: 10.1159/000500460. Epub 2019 Jun 28.
|
| 301 |
Electrophoretic patterns of proteinuria in feline spontaneous chronic kidney disease.J Feline Med Surg. 2020 Feb;22(2):114-121. doi: 10.1177/1098612X19827597. Epub 2019 Feb 6.
|
| 302 |
A miR-1207-5p binding site polymorphism abolishes regulation of HBEGF and is associated with disease severity in CFHR5 nephropathy.PLoS One. 2012;7(2):e31021. doi: 10.1371/journal.pone.0031021. Epub 2012 Feb 2.
|
| 303 |
Role of Cardio-Specific Micro-RibonucleicAcids and Correlation with Cardiac Biomarkers in Acute Coronary Syndrome: A Comprehensive Systematic Review.Cureus. 2019 Oct 9;11(10):e5878. doi: 10.7759/cureus.5878.
|
| 304 |
Ferric citrate reduces fibroblast growth factor 23 levels and improves renal and cardiac function inamouse model of chronic kidney disease.Kidney Int. 2019 Dec;96(6):1346-1358. doi: 10.1016/j.kint.2019.07.026. Epub 2019 Aug 30.
|
| 305 |
Discordant association of the CREBRF rs373863828 A allele with increased BMI and protection from type 2 diabetes in Mori and Pacific (Polynesian) people living in Aotearoa/New Zealand.Diabetologia. 2018 Jul;61(7):1603-1613. doi: 10.1007/s00125-018-4623-1. Epub 2018 May 2.
|
| 306 |
Incidence, Risk Factors, and Outcomes of Transition of Acute Kidney Injury to Chronic Kidney Disease in Cirrhosis: A Prospective Cohort Study.Hepatology. 2020 Mar;71(3):1009-1022. doi: 10.1002/hep.30859. Epub 2019 Oct 24.
|
| 307 |
Acute renal outcomes with sodium-glucose co-transporter-2 inhibitors: Real-world data analysis.Diabetes Obes Metab. 2019 Feb;21(2):340-348. doi: 10.1111/dom.13532. Epub 2018 Oct 15.
|
| 308 |
Activating transcription factor-4 promotes mineralization in vascular smooth muscle cells.JCI Insight. 2016 Nov 3;1(18):e88646. doi: 10.1172/jci.insight.88646.
|
| 309 |
Activated NF-B/Nrf2 and Wnt/-catenin pathways are associated with lipid metabolism in CKD patients with microalbuminuria and macroalbuminuria.Biochim Biophys Acta Mol Basis Dis. 2019 Sep 1;1865(9):2317-2332. doi: 10.1016/j.bbadis.2019.05.010. Epub 2019 May 16.
|
| 310 |
Adropin and irisin in arterial hypertension, diabetes mellitus and chronic kidney disease.Adv Clin Exp Med. 2019 Nov;28(11):1571-1575. doi: 10.17219/acem/104551.
|
| 311 |
Adiponectin is related to markers of endothelial dysfunction and neoangiogenesis in diabetic patients.Int Urol Nephrol. 2018 Sep;50(9):1661-1666. doi: 10.1007/s11255-018-1890-1. Epub 2018 May 26.
|
| 312 |
EXTL2 controls liver regeneration and aortic calcification through xylose kinase-dependent regulation of glycosaminoglycan biosynthesis.Matrix Biol. 2014 Apr;35:18-24. doi: 10.1016/j.matbio.2013.10.010. Epub 2013 Oct 24.
|
| 313 |
Karyomegalic Interstitial Nephritis: A Case Report and Review of the Literature.Medicine (Baltimore). 2016 May;95(20):e3349. doi: 10.1097/MD.0000000000003349.
|
| 314 |
FAR2 is associated with kidney disease in mice and humans.Physiol Genomics. 2018 Aug 1;50(8):543-552. doi: 10.1152/physiolgenomics.00118.2017. Epub 2018 Apr 13.
|
| 315 |
Fetuin-B Links Nonalcoholic Fatty Liver Disease to Chronic Kidney Disease in Obese Chinese Adults: A Cross-Sectional Study.Ann Nutr Metab. 2019;74(4):287-295. doi: 10.1159/000499843. Epub 2019 Apr 9.
|
| 316 |
Nuclear factor erythroid 2-related factor 2 as a treatment target of kidney diseases.Curr Opin Nephrol Hypertens. 2020 Jan;29(1):128-135. doi: 10.1097/MNH.0000000000000556.
|
| 317 |
Familial tumoral calcinosis and the role of O-glycosylation in the maintenance of phosphate homeostasis.Biochim Biophys Acta. 2009 Sep;1792(9):847-52. doi: 10.1016/j.bbadis.2008.10.008. Epub 2008 Oct 25.
|
| 318 |
Association of common gene variants in glucokinase regulatory protein with cardiorenal disease: A systematic review and meta-analysis.PLoS One. 2018 Oct 23;13(10):e0206174. doi: 10.1371/journal.pone.0206174. eCollection 2018.
|
| 319 |
Review of glucagon-like peptide-1 receptor agonists for the treatment of type 2 diabetes mellitus in patients with chronic kidney disease and their renal effects.J Diabetes. 2019 Dec;11(12):938-948. doi: 10.1111/1753-0407.12969. Epub 2019 Aug 14.
|
| 320 |
Activation of GSDMD contributes to acute kidney injury induced by cisplatin.Am J Physiol Renal Physiol. 2020 Jan 1;318(1):F96-F106. doi: 10.1152/ajprenal.00351.2019. Epub 2019 Nov 4.
|
| 321 |
Structural impact analysis of missense SNPs present in the uroguanylin gene by long-term molecular dynamics simulations.J Theor Biol. 2016 Dec 7;410:9-17. doi: 10.1016/j.jtbi.2016.09.008. Epub 2016 Sep 9.
|
| 322 |
Guanylin and uroguanylin regulate electrolyte transport in isolated human cortical collecting ducts.Kidney Int. 2005 Apr;67(4):1420-7. doi: 10.1111/j.1523-1755.2005.00219.x.
|
| 323 |
Screening potential prognostic biomarkers of long non-coding RNAs for predicting the risk of chronic kidney disease.Braz J Med Biol Res. 2019 Nov 7;52(11):e8333. doi: 10.1590/1414-431X20198333. eCollection 2019.
|
| 324 |
Effect of atorvastatin on iron metabolism regulation in patients with chronic kidney disease - a randomized double blind crossover study.Ren Fail. 2018 Nov;40(1):700-709. doi: 10.1080/0886022X.2018.1535983.
|
| 325 |
Interferon (IFN)-Induced Protein 35 (IFI35), a Type I Interferon-Dependent Transcript, Upregulates Inflammatory Signaling Pathways by Activating Toll-Like Receptor 3 in Human Mesangial Cells.Kidney Blood Press Res. 2016;41(5):635-642. doi: 10.1159/000447932. Epub 2016 Sep 17.
|
| 326 |
Elements of Palliative Care in the Last 6Months of Life: Frequency, Predictors, and Timing.J Gen Intern Med. 2020 Mar;35(3):753-761. doi: 10.1007/s11606-019-05349-0. Epub 2019 Oct 24.
|
| 327 |
Electronegative LDL-mediated cardiac electrical remodeling in a rat model of chronic kidney disease.Sci Rep. 2017 Jan 17;7:40676. doi: 10.1038/srep40676.
|
| 328 |
Common charge-shift mutation Glu65Lys in K+ channel ?Subunit KCNMB1: pleiotropic consequences for glomerular filtration rate and progressive renal disease.Am J Nephrol. 2010;32(5):414-24. doi: 10.1159/000320131. Epub 2010 Sep 23.
|
| 329 |
Intelligent Diagnostic Prediction and Classification System for Chronic Kidney Disease.Sci Rep. 2019 Jul 3;9(1):9583. doi: 10.1038/s41598-019-46074-2.
|
| 330 |
Keratin 18 and heat-shock protein in chronic kidney disease.Adv Clin Chem. 2013;62:123-49. doi: 10.1016/b978-0-12-800096-0.00003-2.
|
| 331 |
A novel biomarker of laminin turnover is associated with disease progression and mortality in chronic kidney disease.PLoS One. 2018 Oct 1;13(10):e0204239. doi: 10.1371/journal.pone.0204239. eCollection 2018.
|
| 332 |
Anti-inflammatory effects of Lefty-1 in renal tubulointerstitial inflammation via regulation of the NF-B pathway.Int J Mol Med. 2018 Mar;41(3):1293-1304. doi: 10.3892/ijmm.2017.3327. Epub 2017 Dec 18.
|
| 333 |
Creasensor: SIMPLE technology for creatinine detection in plasma.Anal Chim Acta. 2018 Feb 13;1000:191-198. doi: 10.1016/j.aca.2017.11.026. Epub 2017 Nov 22.
|
| 334 |
Plasma Leucine-Rich -2-Glycoprotein 1 Predicts Rapid eGFR Decline and Albuminuria Progression in Type 2 Diabetes Mellitus.J Clin Endocrinol Metab. 2017 Oct 1;102(10):3683-3691. doi: 10.1210/jc.2017-00930.
|
| 335 |
Colistin Use in Patients with Chronic Kidney Disease: Are We Underdosing Patients?.Molecules. 2019 Feb 1;24(3):530. doi: 10.3390/molecules24030530.
|
| 336 |
Clinical Indices Can Standardize and Monitor Pediatric Care: A Novel Mechanism to Improve Quality and Safety.J Pediatr. 2018 Feb;193:190-195.e1. doi: 10.1016/j.jpeds.2017.09.073. Epub 2017 Dec 6.
|
| 337 |
Personalized Treatment for Small Renal Tumors: Decision Analysis of Competing Causes of Mortality.Radiology. 2019 Mar;290(3):732-743. doi: 10.1148/radiol.2018181114. Epub 2019 Jan 15.
|
| 338 |
Weighted Gene Correlation Network Analysis (WGCNA) Detected Loss of MAGI2 Promotes Chronic Kidney Disease (CKD) by Podocyte Damage.Cell Physiol Biochem. 2018;51(1):244-261. doi: 10.1159/000495205. Epub 2018 Nov 16.
|
| 339 |
Cardiovascular risk of sitagliptin in ischemic stroke patients with type 2 diabetes and chronic kidney disease: A nationwide cohort study.Medicine (Baltimore). 2018 Dec;97(52):e13844. doi: 10.1097/MD.0000000000013844.
|
| 340 |
Effect of diet protein restriction on progression of chronic kidney disease: A systematic review and meta-analysis.PLoS One. 2018 Nov 7;13(11):e0206134. doi: 10.1371/journal.pone.0206134. eCollection 2018.
|
| 341 |
Treatment of Uremic Pruritus: A Systematic Review.Am J Kidney Dis. 2017 Nov;70(5):638-655. doi: 10.1053/j.ajkd.2017.05.018. Epub 2017 Jul 15.
|
| 342 |
Different Abnormalities of Cortical Neural Synchronization Mechanisms in Patients with Mild Cognitive Impairment due to Alzheimer's and Chronic Kidney Diseases: An EEG Study.J Alzheimers Dis. 2018;65(3):897-915. doi: 10.3233/JAD-180245.
|
| 343 |
Identification of an argpyrimidine-modified protein in human red blood cells from schizophrenic patients: A possible biomarker for diseases involving carbonyl stress.Biochem Biophys Res Commun. 2017 Nov 4;493(1):573-577. doi: 10.1016/j.bbrc.2017.08.150. Epub 2017 Sep 1.
|
| 344 |
IgA nephropathy: an update.Curr Opin Nephrol Hypertens. 2017 May;26(3):165-171. doi: 10.1097/MNH.0000000000000312.
|
| 345 |
Evaluation of inactive Matrix-Gla-Protein (MGP) as a biomarker for incident and recurrent kidney stones.J Nephrol. 2020 Feb;33(1):101-107. doi: 10.1007/s40620-019-00623-0. Epub 2019 Jun 20.
|
| 346 |
RIPK3 promotes kidney fibrosis via AKT-dependent ATP citrate lyase.JCI Insight. 2018 Feb 8;3(3):e94979. doi: 10.1172/jci.insight.94979. eCollection 2018 Feb 8.
|
| 347 |
Detrimental effect of renin-angiotensin blockade on progression of chronic kidney disease at later stages: A matter of dosage adjustment?.Nefrologia (Engl Ed). 2020 Jan-Feb;40(1):38-45. doi: 10.1016/j.nefro.2019.02.013. Epub 2019 Jun 10.
|
| 348 |
Spontaneous Extracellular Matrix Accumulation in a Human in vitro Model of Renal Fibrosis Is Mediated by V Integrins.Nephron. 2019;142(4):328-350. doi: 10.1159/000499506. Epub 2019 May 2.
|
| 349 |
Incremental prognostic value of SPECT-MPI in chronic kidney disease: A reclassification analysis.J Nucl Cardiol. 2018 Oct;25(5):1658-1673. doi: 10.1007/s12350-016-0756-0. Epub 2017 Jan 3.
|
| 350 |
Identification of salivary peptidomic biomarkers in chronic kidney disease patients undergoing haemodialysis.Clin Chim Acta. 2019 Feb;489:154-161. doi: 10.1016/j.cca.2018.12.003. Epub 2018 Dec 7.
|
| 351 |
MXRA5 is a TGF-1-regulated human protein with anti-inflammatory and anti-fibrotic properties.J Cell Mol Med. 2017 Jan;21(1):154-164. doi: 10.1111/jcmm.12953. Epub 2016 Sep 6.
|
| 352 |
The incidence, prevalence and trends of Chronic Kidney Disease and Chronic Kidney Disease of uncertain aetiology (CKDu) in the North Central Province of Sri Lanka: an analysis of 30,566 patients.BMC Nephrol. 2019 Aug 28;20(1):338. doi: 10.1186/s12882-019-1501-0.
|
| 353 |
Molecular Markers of Tubulointerstitial Fibrosis and Tubular Cell Damage in Patients with Chronic Kidney Disease.PLoS One. 2015 Aug 28;10(8):e0136994. doi: 10.1371/journal.pone.0136994. eCollection 2015.
|
| 354 |
Stabilization of hypoxia-inducible factor 1 by cobalt chloride impairs podocyte morphology and slit-diaphragm function.J Cell Biochem. 2019 May;120(5):7667-7678. doi: 10.1002/jcb.28041. Epub 2018 Nov 1.
|
| 355 |
Higher Serum Levels of Osteoglycin Are Associated with All-Cause Mortality and Cardiovascular and Cerebrovascular Events in Patients with Advanced Chronic Kidney Disease.Tohoku J Exp Med. 2017 Aug;242(4):281-290. doi: 10.1620/tjem.242.281.
|
| 356 |
Effects of carnitine on oxidative stress response to intravenous iron administration to patients with CKD: impact of haptoglobin phenotype.BMC Nephrol. 2015 Aug 13;16:135. doi: 10.1186/s12882-015-0119-0.
|
| 357 |
Effects of vadadustat on hemoglobin concentrations in patients receiving hemodialysis previously treated with erythropoiesis-stimulating agents.Nephrol Dial Transplant. 2019 Jan 1;34(1):90-99. doi: 10.1093/ndt/gfy055.
|
| 358 |
Elevated serum levels of procollagen C-proteinase enhancer-1 in patients with chronic kidney disease is associated with a declining glomerular filtration rate.Nephrology (Carlton). 2019 Sep;24(9):938-942. doi: 10.1111/nep.13521. Epub 2019 Apr 29.
|
| 359 |
Hypoxia-inducible factor stabilizers for treating anemia of chronic kidney disease.Curr Opin Nephrol Hypertens. 2018 Sep;27(5):331-338. doi: 10.1097/MNH.0000000000000431.
|
| 360 |
Reduction of mitochondria and up regulation of pyruvate dehydrogenase kinase 4 of skeletal muscle in patients with chronic kidney disease.Nephrology (Carlton). 2020 Mar;25(3):230-238. doi: 10.1111/nep.13606. Epub 2019 Jun 7.
|
| 361 |
The association of profilin-1 levels with survival in chronic kidney disease.Eur J Clin Invest. 2017 Dec;47(12). doi: 10.1111/eci.12839. Epub 2017 Oct 27.
|
| 362 |
Association of the salivary triggering receptor expressed on myeloid cells/its ligand peptidoglycan recognition protein 1 axis with oral inflammation in kidney disease.J Periodontol. 2018 Jan;89(1):117-129. doi: 10.1902/jop.2017.170218.
|
| 363 |
CKD autophagy activation and skeletal muscle atrophy-a preliminary study of mitophagy and inflammation.Eur J Clin Nutr. 2019 Jun;73(6):950-960. doi: 10.1038/s41430-018-0381-x. Epub 2019 Jan 3.
|
| 364 |
Papillary renal cell carcinoma with a somatic mutation in MET in a patient with autosomal dominant polycystic kidney disease.Cancer Genet. 2016 Jan-Feb;209(1-2):11-20. doi: 10.1016/j.cancergen.2015.11.002. Epub 2015 Dec 1.
|
| 365 |
Abnormalities in focal adhesion complex formation, regulation, and function in human autosomal recessive polycystic kidney disease epithelial cells.Am J Physiol Cell Physiol. 2010 Apr;298(4):C831-46. doi: 10.1152/ajpcell.00032.2009. Epub 2009 Nov 18.
|
| 366 |
Tubular Peroxiredoxin 3 as a Predictor of Renal Recovery from Acute Tubular Necrosis in Patients with Chronic Kidney Disease.Sci Rep. 2017 Feb 27;7:43589. doi: 10.1038/srep43589.
|
| 367 |
Chronic kidney disease and vitamin D metabolism in human bone marrow-derived MSCs.Ann N Y Acad Sci. 2017 Aug;1402(1):43-55. doi: 10.1111/nyas.13464.
|
| 368 |
The Long Pentraxin PTX3 Is an Endogenous Inhibitor of Hyperoxaluria-Related Nephrocalcinosis and Chronic Kidney Disease.Front Immunol. 2018 Sep 25;9:2173. doi: 10.3389/fimmu.2018.02173. eCollection 2018.
|
| 369 |
Efficacy and safety of once-monthly risedronate in osteoporosis subjects with mild-to-moderate chronic kidney disease: a post hoc subgroup analysis of a phase III trial in Japan.J Bone Miner Metab. 2019 Jul;37(4):730-740. doi: 10.1007/s00774-018-0977-1. Epub 2018 Dec 6.
|
| 370 |
Trans-ethnic Fine Mapping Highlights Kidney-Function Genes Linked to Salt Sensitivity.Am J Hum Genet. 2016 Sep 1;99(3):636-646. doi: 10.1016/j.ajhg.2016.07.012.
|
| 371 |
Hyperphosphatemia induces protective autophagy in endothelial cells through the inhibition of Akt/mTOR signaling.J Vasc Surg. 2015 Jul;62(1):210-221.e2. doi: 10.1016/j.jvs.2014.02.040. Epub 2014 May 3.
|
| 372 |
Renalase gene polymorphism and epinephrine level in chronic kidney disease.Appl Biochem Biotechnol. 2015 Feb;175(4):2309-17. doi: 10.1007/s12010-014-1433-x. Epub 2014 Dec 9.
|
| 373 |
Expression of the NRF2 Target Gene NQO1 Is Enhanced in Mononuclear Cells in Human Chronic Kidney Disease.Oxid Med Cell Longev. 2017;2017:9091879. doi: 10.1155/2017/9091879. Epub 2017 Jul 13.
|
| 374 |
News in pathophysiology, definition and classification of hepatorenal syndrome: A step beyond the International Club of Ascites (ICA) consensus document.J Hepatol. 2019 Oct;71(4):811-822. doi: 10.1016/j.jhep.2019.07.002. Epub 2019 Jul 11.
|
| 375 |
RTN1 mediates progression of kidney disease by inducing ER stress.Nat Commun. 2015 Jul 31;6:7841. doi: 10.1038/ncomms8841.
|
| 376 |
Catch-up growth in children with chronic kidney disease started on enteral feeding after 2 years of age.Pediatr Nephrol. 2020 Jan;35(1):113-118. doi: 10.1007/s00467-019-04382-9. Epub 2019 Oct 24.
|
| 377 |
Heterozygous Loss-of-Function SEC61A1 Mutations Cause Autosomal-Dominant Tubulo-Interstitial and Glomerulocystic Kidney Disease with Anemia.Am J Hum Genet. 2016 Jul 7;99(1):174-87. doi: 10.1016/j.ajhg.2016.05.028.
|
| 378 |
Circulating secreted frizzled-related protein 5 and chronic kidney disease in patients with acute ST-segment elevation myocardial infarction.Cytokine. 2018 Oct;110:367-373. doi: 10.1016/j.cyto.2018.04.009. Epub 2018 May 25.
|
| 379 |
Evaluation of the new Sebia free light chain assay using the AP22 ELITE instrument.Clin Chim Acta. 2018 Dec;487:161-167. doi: 10.1016/j.cca.2018.09.030. Epub 2018 Sep 20.
|
| 380 |
Role of Cytosolic Serine Hydroxymethyl Transferase 1 (SHMT1) in Phosphate-Induced Vascular Smooth Muscle Cell Calcification.Kidney Blood Press Res. 2018;43(4):1212-1221. doi: 10.1159/000492248. Epub 2018 Aug 2.
|
| 381 |
Barley--glucans reduce systemic inflammation, renal injury and aortic calcification through ADAM17 and neutral-sphingomyelinase2 inhibition.Sci Rep. 2019 Nov 28;9(1):17810. doi: 10.1038/s41598-019-54306-8.
|
| 382 |
Targeting STUB1-tissue factor axis normalizes hyperthrombotic uremic phenotype without increasing bleeding risk.Sci Transl Med. 2017 Nov 22;9(417):eaam8475. doi: 10.1126/scitranslmed.aam8475.
|
| 383 |
Sodium bicarbonate loading limits tubular cast formation independent of glomerular injury and proteinuria in Dahl salt-sensitive rats.Clin Sci (Lond). 2018 Jun 20;132(11):1179-1197. doi: 10.1042/CS20171630. Print 2018 Jun 15.
|
| 384 |
Increased trefoil factor 2 levels in patients with chronic kidney disease.PLoS One. 2017 Mar 29;12(3):e0174551. doi: 10.1371/journal.pone.0174551. eCollection 2017.
|
| 385 |
The Application of T.SPOT-TB Assay for Early Diagnosis of Active Tuberculosis in Chronic Kidney Disease Patients Receiving Immunosuppressive Treatment.J Invest Surg. 2020 Oct;33(9):853-858. doi: 10.1080/08941939.2019.1566417. Epub 2019 Mar 27.
|
| 386 |
Uremia Impacts VE-Cadherin and ZO-1 Expression in Human Endothelial Cell-to-Cell Junctions.Toxins (Basel). 2018 Oct 7;10(10):404. doi: 10.3390/toxins10100404.
|
| 387 |
Transmembrane protein 126B protects against high fat diet (HFD)-induced renal injury by suppressing dyslipidemia via inhibitionof ROS.Biochem Biophys Res Commun. 2019 Jan 29;509(1):40-47. doi: 10.1016/j.bbrc.2018.12.003. Epub 2018 Dec 20.
|
| 388 |
High-dose HOOK effect in urinary DcR2 assay in patients with chronic kidney disease.Clin Biochem. 2018 Aug;58:32-36. doi: 10.1016/j.clinbiochem.2018.06.001. Epub 2018 Jun 5.
|
| 389 |
A Drosophila model of insulin resistance associated with the human TRIB3 Q/R polymorphism.Dis Model Mech. 2017 Dec 19;10(12):1453-1464. doi: 10.1242/dmm.030619.
|
| 390 |
Effects of the Administration of 25(OH) Vitamin D3 in an Experimental Model of Chronic Kidney Disease in Animals Null for 1-Alpha-Hydroxylase.PLoS One. 2017 Jan 20;12(1):e0170654. doi: 10.1371/journal.pone.0170654. eCollection 2017.
|
| 391 |
Genetic polymorphisms and the risk of accelerated renal function decline in women.PLoS One. 2009;4(3):e4787. doi: 10.1371/journal.pone.0004787. Epub 2009 Mar 10.
|
| 392 |
Association of sickle cell trait with chronic kidney disease and albuminuria in African Americans.JAMA. 2014 Nov 26;312(20):2115-25. doi: 10.1001/jama.2014.15063.
|
| 393 |
Association of gene polymorphisms with chronic kidney disease in Japanese individuals.Int J Mol Med. 2009 Oct;24(4):539-47. doi: 10.3892/ijmm_00000263.
|
| 394 |
C4A deficiency and poor prognosis in patients with IgA nephropathy.Clin Nephrol. 1991 Jul;36(1):1-5.
|
| 395 |
Urinary mRNA expression of CCN2/CCN3 as a noninvasive marker for monitoring glomerular structure changes in nondiabetic chronic kidney disease.Biomarkers. 2012 Dec;17(8):714-20. doi: 10.3109/1354750X.2012.722229. Epub 2012 Oct 15.
|
| 396 |
Expression of parafibromin in distant metastatic parathyroid tumors in patients with advanced secondary hyperparathyroidism due to chronic kidney disease.World J Surg. 2008 May;32(5):815-21. doi: 10.1007/s00268-007-9458-8.
|
| 397 |
Indoxyl sulfate signals for rapid mRNA stabilization of Cbp/p300-interacting transactivator with Glu/Asp-rich carboxy-terminal domain 2 (CITED2) and suppresses the expression of hypoxia-inducible genes in experimental CKD and uremia.FASEB J. 2013 Oct;27(10):4059-75. doi: 10.1096/fj.13-231837. Epub 2013 Jun 21.
|
| 398 |
Claudin-19 mutations and clinical phenotype in Spanish patients with familial hypomagnesemia with hypercalciuria and nephrocalcinosis.PLoS One. 2013;8(1):e53151. doi: 10.1371/journal.pone.0053151. Epub 2013 Jan 3.
|
| 399 |
Genetic risk for myocardial infarction in Japanese individuals with or without chronic kidney disease.Int J Mol Med. 2010 May;25(5):743-9. doi: 10.3892/ijmm_00000400.
|
| 400 |
Association of CYBA rs7195830 polymorphism with estimated glomerular filtration rate in an adult Han sample from Jiangsu province, China.Chin Med J (Engl). 2013;126(17):3311-5.
|
| 401 |
Protection against loss of innate defenses in adulthood by low advanced glycation end products (AGE) intake: role of the antiinflammatory AGE receptor-1.J Clin Endocrinol Metab. 2009 Nov;94(11):4483-91. doi: 10.1210/jc.2009-0089. Epub 2009 Oct 9.
|
| 402 |
DNA hypermethylation and DNA hypomethylation is present at different loci in chronic kidney disease.Epigenetics. 2014 Mar;9(3):366-76. doi: 10.4161/epi.27161. Epub 2013 Nov 19.
|
| 403 |
Bone biopsy practice patterns across Europe: the European renal osteodystrophy initiative-a position paper.Nephrol Dial Transplant. 2017 Oct 1;32(10):1608-1613. doi: 10.1093/ndt/gfw468.
|
| 404 |
Serum Erythroferrone Levels Associate with Mortality and Cardiovascular Events in Hemodialysis and in CKD Patients: A Two Cohorts Study.J Clin Med. 2019 Apr 16;8(4):523. doi: 10.3390/jcm8040523.
|
| 405 |
Genome-wide association study for renal traits in the Framingham Heart and Atherosclerosis Risk in Communities Studies.BMC Med Genet. 2008 Jun 3;9:49. doi: 10.1186/1471-2350-9-49.
|
| 406 |
Identification of chromosome 3q28 and ALPK1 as susceptibility loci for chronic kidney disease in Japanese individuals by a genome-wide association study.J Med Genet. 2013 Jun;50(6):410-8. doi: 10.1136/jmedgenet-2013-101518. Epub 2013 Mar 28.
|
| 407 |
Association of a polymorphism of the apolipoprotein E gene with chronic kidney disease in Japanese individuals with metabolic syndrome.Genomics. 2009 Mar;93(3):221-6. doi: 10.1016/j.ygeno.2008.11.001. Epub 2008 Dec 6.
|
| 408 |
Intestinal fatty acid-binding protein levels in patients with chronic renal failure.J Surg Res. 2018 Oct;230:94-100. doi: 10.1016/j.jss.2018.04.057. Epub 2018 May 25.
|
| 409 |
Increased Serum Interleukin-34 Levels Are Related to the Presence and Severity of Cardiac Dysfunction in Patients With Ischemic Cardiomyopathy.Front Physiol. 2018 Jul 11;9:904. doi: 10.3389/fphys.2018.00904. eCollection 2018.
|
| 410 |
Multiple loci associated with indices of renal function and chronic kidney disease.Nat Genet. 2009 Jun;41(6):712-7. doi: 10.1038/ng.377. Epub 2009 May 10.
|
| 411 |
Decreased microRNA is involved in the vascular remodeling abnormalities in chronic kidney disease (CKD).PLoS One. 2013 May 22;8(5):e64558. doi: 10.1371/journal.pone.0064558. Print 2013.
|
| 412 |
Functional proteins involved in regulation of intracellular Ca(2+) for drug development: the extracellular calcium receptor and an innovative medical approach to control secondary hyperparathyroidism by calcimimetics.J Pharmacol Sci. 2005 Mar;97(3):355-60. doi: 10.1254/jphs.fmj04007x6. Epub 2005 Mar 17.
|
| 413 |
Poricoic acid A enhances melatonin inhibition of AKI-to-CKD transition by regulating Gas6/AxlNFB/Nrf2 axis.Free Radic Biol Med. 2019 Apr;134:484-497. doi: 10.1016/j.freeradbiomed.2019.01.046. Epub 2019 Feb 2.
|
| 414 |
Genetic variance in ABCB1 and CYP3A5 does not contribute toward the development of chronic kidney disease after liver transplantation.Pharmacogenet Genomics. 2014 Sep;24(9):427-35. doi: 10.1097/FPC.0000000000000063.
|
| 415 |
New PAX2 heterozygous mutation in a child with chronic kidney disease: a case report and review of the literature.BMC Nephrol. 2018 Sep 21;19(1):245. doi: 10.1186/s12882-018-1044-9.
|
| 416 |
Serum and urinary SOD3 in patients with type 2 diabetes: comparison with early chronic kidney disease patients and association with development of diabetic nephropathy.Am J Physiol Renal Physiol. 2019 Jan 1;316(1):F32-F41. doi: 10.1152/ajprenal.00401.2017. Epub 2018 Oct 10.
|
|
|
|
|
|
|
